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Increased systemic infections and growing resistance of Candida species in 
immunosuppressed people have prompted research for additional treatment options.  The 
purpose of this quantitative study was to investigate the potential of lemongrass, oregano, 
and thyme essential oils tested individually, combined, and combined with the antifungal 
agents fluconazole and caspofungin to kill Candida albicans isolates in a controlled 
laboratory setting.  This study was grounded on the theoretical concepts of the 
epidemiologic triangle model.  The experimental data collected were used to investigate 
risk factors related to age, gender, race, and comorbidities.  Kill rates of lemongrass, 
oregano, and thyme essential oils individually and combined, kill rates of fluconazole, 
caspofungin, and the kill rates when the antifungals were each combined with the 3 
essential oils were compared using 117 isolates recovered from bloodstream infections 
between January 2009 through August 1, 2017.  The data collected were analyzed using 
2-way repeated ANOVAS.  According to study results, there were statistically significant 
increases in kill rates when the isolates were exposed to any of the combinations of 
essential oils tested.  Using binomial and multinomial regression to analyze age, gender, 
race, and comorbidities resulted in the age group 25-34, kidney failure, and solid organ 
tumor cancer all being statistically significantly associated with an increased risk for 
Candida albicans bloodstream infections, and multiple organ failure negatively 
associated with the risk.  Health care practitioners can use the results of this study to 
reduce the number of patients becoming infected with life-threatening yeast infections, 
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Chapter 1: Introduction to the Study  
Introduction 
Candida infections are considered the second most numerous cause of fungal 
infections worldwide (Brown et al., 2012).  Although most infections are superficial, 
invasive fungal infections, including those caused by Candida, are responsible for over 
an estimated 1.5 million infections annually worldwide (Brown et al., 2012).  An accurate 
measurement of the burden of fungal disease is likely underestimated due to misdiagnosis 
and the lack of required reporting in the United States for all invasive fungal disease 
except for Coccidiodes, which causes Valley Fever (Brown et al., 2012).  The Centers for 
Disease Control and Prevention (CDC, n.d.2) collects data on invasive candidiasis 
through the Emerging Infections Programs (EIP) from 10 state health departments; these 
states’ local health departments; academic institutions; as well as other federal agencies, 
public health and clinical laboratories, and health care facilities.  Increased numbers of 
successful organ transplants, as well as improvements in medical treatments for 
HIV/AIDS and cancers, have created an increasing number of patients who are 
immunosuppressed for extended lengths of time (Pellegrino, Onder, & Schmidt, n.d.).  
This rise in at-risk populations has caused an increase in organisms that are considered 
pathogenic, as well as the development of Candida isolates that are resistant to the 
limited available treatment options (Cleveland et al., 2012).  Additional difficulties occur 
with being able to detect and treat these infections quickly as initial symptoms may be 






Through the CDC’s EIP program, data are also collected through active, 
population-based surveillance for candidemia in seven of the current EIP sites: Georgia, 
Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee (CDC, 2017).  
However, epidemiology studies on overall incidence of invasive Candida have been 
difficult to determine due to a lack of required reporting in other areas and the potential 
for misdiagnosis (Brown et al., 2012).  Some scholars have evaluated the status of 
antifungal resistance epidemiology in haematological malignant patients (Alcazar-Fuoli 
& Mellado, 2014).  Researchers have reported on the mechanisms of the virulence factors 
of Candida species and the ability to cause severe infections (Bliss et al., 2012).  This 
knowledge added to the need to analyze the potential for Candida species to possess 
adaptive resistance mechanisms, the prevalence of these resistant organisms in certain 
patient populations, and the discrepancy that exists between in-vitro and in-vivo results 
due to how the host responds differently between colonizing Candida and invasive 
Candida (Lewis, Viale, & Kontoyiannis, 2012).   
Studies on various essential oils and the effect on survival of yeast and bacteria 
have brought additional areas for further investigation.  Groundwork for treating Candida 
with essential oils in-vivo and the chemical compounds that cause disruption or death to 
yeast cells have also been studied using essential oils extracted from oregano plants 
(Cleff et al., 2010).  The inhibition of Candida albicans and Aspergillus fumagatus with 
thyme essential oil has also been studied.  Thyme sterilized culture growth of both 




essential oils against two quality control strains of Candida albicans alone and in 
conjunction with fluconazole and amphotericin B.  All of these essential oils had various 
degrees of efficacy against strains, including the resistance strain.  Sajjad Ahmad Khan et 
al. (2012), however, did not test any essential oils against patient recovered isolates.  Rath 
and Mohapatra (2015) studied the effect of black cumin, curry leaf, Ajwain, and Betel 
leaf against Candida albicans, Candida tropicalis, Candida glabrata, and Candida 
parapsilosis.  Rath and Mohapatra found that essential oils showed efficacy against the 
various strains of Candida, even after the oils were autoclaved.  Although Rath and 
Mohapatra had multiple species of Candida, the essential oils that were tested would not 
be readily available in the United States.  Rath and Mohapatra, however, tested the 
efficacy of essential oils after exposure to intense heat (from an autoclave).  Different 
mechanisms of delivery of essential oils to Candida isolates were evaluated by testing the 
minimum inhibitory concentration in vapor and gas phase for various essential oils, and it 
was determined that Cymbopogon citratus (lemongrass) was highly effective in the vapor 
phase against Candida due to the ability for the essential oils to change surface structures 
on the yeast cell walls in a short time (Tyagi & Malik, 2010).  The potential to diffuse 
essential oils into the air may provide a treatment option not only for a patient but also for 
the environment and, thus, disrupt the ability of the yeast to maintain contact with the 
patient through the host environment. 
Age, gender, and an immunocompromised state have been shown to be associated 
with the risk of blood stream infections (Kaye et al., 2011; Yang et al., 2014).  Scholars 




Candida albicans blood stream infections.  The opportunity to examine data and 
investigate Candida albicans isolated from blood stream infections from a large teaching 
hospital with patients who are immunocompromised for various reasons provided an area 
of study that has not been previously published and could add significantly to the body of 
knowledge.  This study could provide a foundation for further research involving patients 
to improve outcomes and empower individuals in treatment options.  
Problem Statement 
Improvements in medical treatments for cancer, HIV/AIDS, as well as a rise in 
successful organ transplants have created an increased number of long-term 
immunosuppressed people (Pellegrino et al., n.d.).  This immunosuppression has caused 
an increase in life-threatening fungal and yeast infections (CDC, 2011).  There is a 
growing problem with ineffective treatment methods for life-threatening yeast infections 
in immunocompromised patients.  Treatment options for Candida infections have 
become limited due to resistance of the organism to multiple antifungal medications 
(Brown et al., 2012).  This problem has caused not only an increased cost for treatment, 
but also an elevated risk of mortality for patients infected with Candida (Zaoutis et al., 
2005).  Fewer traditional treatment options, along with increased mortality rates in both 
children and adults with Candida infections, necessitates different methods and new 
tactics to treat these life-threatening infections (Zaoutis et al., 2005).   
Traditional treatments for Candida infections include antifungal medications, 
such as fluconazole and amphotericin B (CDC MASTER, n.d.).  These drugs, however, 




rise (CDC, 2011).  There are limited treatment options against Candida infections when 
the organism has become resistant to multiple medications (Brown et al., 2012).  This 
problem has increased the risk of mortality in infected patients (Zaoutis et al., 2005).  
Essential oils may provide a synergistic treatment to improve antifungal medication 
activity against Candida albicans (Sajjad Ahmad Khan et al., 2012).  In investigations of 
mechanisms that create antifungal activity in the chemical compounds found in essential 
oils naturally derived from plants, Khan et al. (2011) suggested that these compounds can 
cause lesions in the membrane of the yeast cell wall, alter the permeability of the plasma 
membrane, or cause oxidative stress to the organism.  Despite results from scholars who 
indicated promising in-vitro results from the efficacy of essential oil treatment against 
Candida and its virulence properties, there are limited treatment options used for 
multidrug resistant Candida infections (Tyagi & Malik, 2010).   
Purpose of the Study 
The purpose of this study was to develop a system to examine the potential of 
three essential oils (lemongrass, oregano, and thyme) tested individually, combined, and 
then combined in conjunction with antifungal medications to kill Candida albicans 
isolates in a controlled laboratory setting.  An experimental, quantitative method was 
used to evaluate the impact that the use of these oils, in combination with antifungal 
medications, had on the ability to minimize or prevent virulence factors, as well as the 
potential to kill Candida albicans isolates in laboratory in-vitro testing.  Candida 
albicans isolates were collected from previously saved organisms that were recovered 




age, gender, race, and comorbidities were also collected from the isolates to investigate 
any significance related to Candida albicans infections and these covariates.  In this 
study, I wished to develop a framework to examine the in-vitro effectiveness of three 
separate essential oils used separately and together in the presence of any antifungal 
medications an immunocompromised patient may be prescribed.   
Research Questions and Hypotheses 
1. RQ1: How does the use of lemongrass essential oil compare to standard 
antifungal medications for Candida albicans kill rates in laboratory testing? 
H01: There is no significant difference in kill rates for the use of 
lemongrass essential oil compared to standard antifungal medications for Candida 
albicans in laboratory testing. 
Ha1: There is a significant difference in kill rates for the use of lemongrass 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
2. RQ2: How does the use of oregano essential oil compare to standard antifungal 
medications for Candida albicans kill rates in laboratory testing? 
H02: There is no significant difference in kill rates for the use of oregano 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Ha2: There is a significant difference in kill rates for the use of oregano 





3. RQ3: How does the use of thyme essential oil compare to standard antifungal 
medications for Candida albicans kill rates in laboratory testing? 
H03: There is no significant difference in kill rates for the use of thyme 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Ha3: There is a significant difference in kill rates for the use of thyme 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
4. RQ4: How does the combined use of lemongrass, oregano, and thyme essential 
oils compare to standard antifungal medications for Candida albicans kill rates in 
laboratory testing? 
H04: There is no significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils compared to standard antifungal 
medications for Candida albicans in laboratory testing. 
Ha4: There is a significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils compared to standard antifungal 
medications for Candida albicans in laboratory testing. 
5. RQ5: How does the combined use of lemongrass, oregano, and thyme essential 
oils when used with standard antifungal treatments compare to standard antifungal 
medications for Candida albicans kill rates in laboratory testing?  
H05: There is no significant difference in kill rates for the combined use of 




medications compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
 Ha5: There is a significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils when used with standard antifungal 
medications compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
6. RQ6: How does the combined use of lemongrass, oregano, and thyme essential 
oils compare to standard antifungal medications for disruption of the virulence 
factor of germ tube production of Candida albicans in laboratory testing? 
H06: There is no significant difference in the combined use of lemongrass, 
oregano, and thyme essential oils compared to standard antifungal medications for 
disruption of the virulence factor of germ tube production of Candida albicans in 
laboratory testing. 
Ha6: There is a significant difference in the combined use of lemongrass, 
oregano, and thyme essential oils compared to standard antifungal medications for 
disruption of the virulence factor of germ tube production of Candida albicans in 
laboratory testing. 
7. RQ7: How do the covariates age, gender, race, or comorbidities contribute to the 
risk of Candida albicans bloodstream infections? 
H07: Age, gender, race, or comorbidities do not significantly contribute to 




Ha7: Age, gender, race, or comorbidities do significantly contribute to an 
increased risk of Candida albicans blood stream infections. 
Theoretical Framework 
The epidemiological triangle was used as the framework for the research.  The 
epidemiological triangle provides a model that is based on the premise that disease does 
not occur randomly throughout a population; instead, certain members of this population 
may have a higher risk for a disease that does not randomly occur throughout the rest of 
the population (Soumpasis, Knapp, & Pitt, 2015).  The triangle can also be used to help to 
identify increased risk factors for development of disease in these subpopulations (CDC, 
2016).  This model of causation is composed of a susceptible host, an external agent, and 
the environment in which the host and the agent are in contact with each other (Orr, 
2005).  Contact brings about the disease as the environment provides the means of 
transmission of the infectious agent into the susceptible host (CDC, 2016).  In order to 
develop public health control measures of infectious diseases, all three components and 
how they interact need to be assessed (CDC, n.d.).  Using the epidemiologic triangle as a 
framework for the research provided a foundation of an immunocompromised host, 
which can be placed into the susceptible host vertex, Candida albicans, which is placed 
at the agent vertex, and the environment which is at the final vertex of the triangle.  In 
this study, I evaluated potential means to disrupt this interaction from causing disease by 
breaking one of the sides of the triangle.  In addition, the relationship of these three 
components that enables disease to occur was also used for interpretation of the results 




would disrupt the interaction of the agent to enter and cause disease in the host.  Other 
areas of disruption could involve prevention of the agent from replicating and surviving 
in either the host or the environment.  Although I focused on prevention of virulence 
factor development, as well as yeast cell inhibition and death, this framework also has 
future implications for disruption of the yeast in the environment (see Figures 1 and 2). 
 





Figure 2.  Disruption of epidemiological triangle. 
 
Nature of the Study 
The nature of this study was quantitative.  An experimental study design was used 
to evaluate any impact that the use of lemongrass, oregano, and thyme essential oils 
individually had on Candida albicans kill rates in the laboratory, followed by the 
combined use of these essential oils compared to standard antifungal medications kill 
rates of Candida albicans in laboratory testing.  Next, the combined use of lemongrass, 
oregano, and thyme essential oils, along with standard antifungal treatments, were 
compared to standard antifungal medications for Candida albicans kill rates in laboratory 




compared to standard antifungal medications for the ability to cause disruption of germ 
tube production of Candida albicans in laboratory testing.  This design method provided 
a way to assure a high degree of validity with the ability to culture each Candida isolate 
before and after testing, as well as enabling the research to be duplicated (Frankfort-
Nachmias & Nachmias, 2007). 
Definitions 
Chirality: Pertains to a molecule’s characteristic mirror image, which was used to 
assess that the essential oil tested does not contain synthetic constituents (doTERRA 
CPTG Certified Pure Therapeutic Grade Quality Testing, 2016). 
Cytotoxic effects: Causes harm to cells primarily through cell wall disruption, 
which can decrease the cell’s functions or cause cell death (Ramage et al., 2012). 
Comorbidities: Preexisting conditions or chronic diseases that are listed upon 
admission to the hospital. 
Fournier transfer infrared spectroscopy: Used to identify structural components 
of compounds found in essential oils.  This was used to determine the quality of the 
sample based upon previously recognized high-quality standards (doTERRA CPTG 
Certified Pure Therapeutic Grade Quality Testing, 2016).  
Fungicidal: A compound that kills fungus including yeast (Bachmann et al., 
2002). 
Fungistatic: A compound that inhibits fungus but does not kill it.  When the 




Germ tube: A pseudo-hyphal extension that is used by Candida albicans to invade 
the host mucosal membrane (Bliss et al., 2012). 
Haematological malignant patients: Patients with cancer involving the blood and 
lymphatic system (Alcazar-Fuoli & Mellado, 2014). 
Invasive fungal disease: A fungal infection that has spread to one or more systems 
or organs in the host (Enoch, Ludlam, & Brown, 2006). 
Minimum inhibitory concentration: The lowest concentration of an antimicrobial 
that will inhibit visible growth (Clinical and Laboratory Standards Institute [CLSI], 
2015). 
Nitric oxide: A free radical found in the body that is used for multiple cellular 
processes (Leyva-Lopez, Nair, Bank, Cisneros-Zevallos, & Heredia, 2016). 
Prophylaxis: An antifungal medication taken to prevent an infection (Sanguinetti, 
Posteraro, & Lass-Florl, 2015). 
Reactive oxygen species: A byproduct from cellular oxygen metabolism that can 
cause severe cellular damage in high amounts (Leyva-Lopez et al., 2016). 
Tissue conditioner: A temporary lining that is placed between dentures and the 
gum to promote healing of the gum tissue (Amornvit, Choonharuangdej, & Srithavaj, 
2014). 
Assumptions 
Essential oil components are effective against Candida albicans isolates (Bellete 
et al., 2012; Khan et al., 2011; Sajjad Ahmad Khan et al., 2012).  Essential oil 




Candida albicans strains isolated from patients as well as established Candida albicans 
quality control strains (Bellete et al., 2012; Kalemba & Kunicka, 2003; Khan et al., 2011; 
Korenblum et al., 2013; Rath & Mohapatra, 2015; Shah et al., 2011).  In this study I 
assumed that the samples taken from a large teaching hospital also provided a variety of 
patient demographics due to the diversity of adult patient population seen at the hospital.  
The methods used to evaluate sensitivity of Candida albicans isolates to the essential oils 
and antifungals were assumed to be accurate based upon established scientific methods 
used to determine antimicrobial susceptibility ranges for various organisms including 
Candida albicans (CLSI, 2015).  Time to kill rates were also assumed to be accurate 
based upon previously established laboratory standards and would be reproducible upon 
repeat testing (Woolfrey, Lally, & Tait, 1986). 
Scope and Delimitations 
I used patient demographics and isolates recovered from the patient population of 
a large teaching hospital.  The purpose of this research was to not only evaluate the effect 
of lemongrass, oregano, and thyme essential oils against Candida albicans but to also 
investigate any potential risk factors of people who acquire Candida albicans 
bloodstream infections during their patient stay at the hospital.  Other variables and 
conditions that could further impact risk for Candida albicans bloodstream infections, 
such as potential ubiquitous nature of Candida albicans in this hospital as opposed to 
other hospital locations and risk factors based upon population ethnicities that are not 
generally seen in this geographic location, were outside the scope of this research.  The 




assessed.  Isolates and patient information spanned 7 years in order to obtain an adequate 
sample, and there was potential that the risk factors as well as the characteristics of the 
Candida albicans isolates may vary over this time period and may, therefore, not provide 
accurate information of current risk factors. 
Limitations 
Limitations for this study included potential changes in treatment protocols for the 
time-period examined, the ability to grow the organisms that have been previously 
frozen, and using a local patient population and not a nationwide population.  Collecting 
data from a large teaching hospital’s patient population may also limit the validity of 
overall effectiveness of essential oil treatment in other patient populations.  Other 
limitations included not being able to use actual patients’ interactions with essential oils 
in conjunction with the antifungal treatments.  Only using Candida albicans strains 
isolated from blood stream infections instead of isolates from less life-threatening 
Candida albicans infections and not investigating other emerging yeast pathogens were 
also known limitations for this study. 
Significance of the Study 
To address these gaps in knowledge, I evaluated a large number of clinically 
isolated Candida albicans with various susceptibility patterns.  The impact that the 
essential oils have on Candida isolates was assessed to determine whether essential oil 
treatments could be used to improve outcomes of patients infected with Candida.  This 
research is important for people who are immunocompromised and living with chronic 




term prophylactic treatment with antifungal medications who are at risk of developing 
infections with multidrug resistant Candida species (Wanke, Dos Santos Lazera, & 
Nucci, 2000).  The findings from this research could provide positive social change by 
reducing the number of patients becoming infected with life-threatening yeast infections, 
which not only would reduce mortality but would also reduce the costs associated with 
serious infections.  There is the possibility for the results of this research to provide 
alternative options for treatment, to provide methods for improving treatment, and for 
future research to enable patients to feel empowered in treatment options.  This study also 
has potential to become a foundation for other studies including in-vivo treatment with 
immunocompromised adults as well as within other populations including pediatrics, 
where treatment options due to patient age are even more limited (Bliss et al., 2012). 
Summary and Transition 
This research dissertation has five sections.  In Chapter 1, I presented an overview 
of the problem and why the research was performed.  Current limited treatment options 
have provided opportunities to seek additional methods to improve treatment capabilities.  
Few studies have been done using widely available essential oils and commonly used 
antifungal medications with a large number of clinically significant isolates of Candida 
albicans.  This study provided an opportunity to examine experimental attributes as well 
as investigating covariates as risk factors for Candida albicans infections. 
Chapter 2 provides an in-depth literature review on attributes of Candida 
albicans, alternative treatments, and covariates associated with risk of infection.  This 




stream infections; immunocompromised patients and prophylaxis; virulence and 
resistance mechanisms of Candida albicans; alternative treatment options; host defense 
mechanisms; essential oil treatment testing; chemical mechanisms of actions for 
lemongrass, oregano, and thyme; combining use of essential oils and antimicrobials; host 
cell toxicity to essential oils; and methodology.  In Chapter 3, I describe the design of the 
study, methodologies used, the study population, testing procedures, and variables tested.  
In Chapter 4, I discuss the results of the research that was performed including data 
collection, treatment methods, analyses of statistical test, and a summary of these results.  
In Chapter 5, I finish with the conclusion of these results, limitations of the study, 




Chapter 2: Literature Review 
Introduction 
The CDC (2013) reported that Candida species is the fourth leading cause of 
health-care-associated bloodstream infections.  Hospital life-threatening yeast infections 
in immunocompromised patients have become more difficult to treat due to resistance to 
multiple antifungal medications (Brown et al., 2012).  This growing problem of finding 
effective treatment options has not only caused the cost for treatment to rise but has also 
contributed to rising mortality rates in both adults and children.  Traditional treatment for 
Candida infections include fluconazole and amphotericin B (CDC MASTER,n.d.); 
however, although these drugs are known to be toxic to the body, limited available 
antifungal medications have left few other options (CDC, 2011).   
Researchers have proposed that chemical compounds found in essential oils 
naturally derived from plants can inhibit yeast and fungus and may also provide a 
synergistic treatment to improve antifungal medication activity against Candida albicans 
in-vitro (Sajjad Ahmad Khan et al., 2012).  Although there has been promising in-vitro 
results indicating efficacy of essential oil treatment options for multidrug resistant 
Candida infections, there are limited options used for treatment of these dangerous 
infections (Tyagi & Malik, 2010).   
In this chapter, I review the literature related to Candida virulence factors, the 
disruption of virulence properties using antifungal medications, drug resistance 
mechanisms of Candida albicans, and outcomes for Candida species when exposed to 




viable treatment options for Candida albicans infections based upon published, evidence-
based, scientific research, as well as any risk factors of Candida bloodstream infections 
that have been shown to be related to age, gender, race, and comorbidities. 
Literature Search Strategy 
Articles were chosen using the CINAHL and MEDLINE simultaneous database 
search.  Inclusion parameters included peer-reviewed articles from 2000 to the present, 
full-text available, and written in English.  Exclusions included abstract only, articles not 
peer reviewed, articles in another language, and articles that had limited number of 
samples or patients tested (fewer than five).  Although the initial intent was to limit the 
research articles to the past 5 years, some of the primary investigations and research were 
published prior to 2011.  Initial keywords used were Candida and essential oils.  This 
search brought results for 489 articles.  There were many articles from research 
performed outside of the United States and with oils other than the three used for this 
research project.  A review of the first 10 articles provided four articles for review.  
Another search with the keywords Candida, thyme, and essential oil yielded 22 articles, 
but when the date was adjusted to the last 5 years, there were only two articles, and 
neither were selected.  The next search for Candida and oregano from the last 5 years 
resulted in one article that related to the research topic.  The additional search for 
Candida and lemongrass also revealed one article that was relevant to the research.  
Although multiple articles with Candida and essential oils have been published in the 
past 5 years and even more in the past 10 years, there were few articles of research 




against Candida are common; however, as traditional treatment methods become less 
viable, alternative solutions could become more acceptable for common treatment 
practice.  The remaining articles were found while working in a large teaching hospital 
and in the reference sections of other articles. 
Articles were chosen based upon topics that included inhibition of Candida 
virulence factors, research on how antifungal medications target yeast cell walls, 
investigations of essential oils and their antifungal properties, synergy of essential oils 
and antimicrobials, and interaction of Candida virulence factors with the host response.  
Additional articles relating to potential risk factors for Candida bloodstream infections in 
adults were also reviewed.  Articles were excluded for review if the organisms tested 
were only quality control organisms and did not include patient acquired organisms, if the 
methods section was too limited to determine testing validity, or if the articles were not 
peer reviewed. 
Theoretical Framework 
Theoretical frameworks included in this chapter include theories such as the 
immuno-epidemiological theory of host interaction with antimicrobial medicine and 
infectious microorganisms.  Adaptive genetic theory was also used in studies where the 
researchers were investigating mutations and the ability for the organism to respond to 
stressors to promote organism survival (Ene et al., 2012).  In addition, researchers have 
developed multiple theories that provide a framework for experimental studies, such as 
the germ theory from Pasteur that is based upon the knowledge that microorganisms 




identify the correct organism that causes a disease, a set of criteria must be met in order 
to conclude that the organism causes the disease; and the metabolic control theory where 
a set of genes in a linear processing chain inside the microorganism can be used to predict 
epistasis in antibiotic resistance (MacLean, 2010). 
Although previous researchers may have different frameworks for the foundation 
of the study, these theories can all be related to the epidemiologic triangle.  The 
epidemiologic triangle is a model that is based on the understanding that disease does not 
occur randomly throughout a population; rather, certain members of this population may 
have an increased risk for a disease that does not just randomly occur throughout the 
population (Soumpasis et al., 2015).  The triangle can also be useful to identify increased 
risk factors for development of diseases in these subpopulations (CDC, n.d.).  This type 
of causation model is composed of a susceptible host, an external agent, and the 
environment in which the host and the agent are in contact with each other (Orr, 2005).  
Contact within the host’s environment provides the mode of transmission of the 
infectious agent into the susceptible host (CDC, n.d.).  Assessment of this interaction is 
necessary to develop public health control measures for infectious diseases (CDC, n.d.).  
This triangle of interaction has been used to research modes of transmission of 
Clostridium difficile that traditionally had been found only in patients who had been 
hospitalized but is now commonly found in community settings.  The way to interrupt 
this disease process is to decrease the likelihood of the organism from being transferred 
into new environments from infected or carrier hosts (Gupta & Khanna, 2014).  This type 




formation from Candida albicans in susceptible hosts.  Interventions that interrupt the 
environmental factors associated with the risks of otitis media, such as nutrition, air 
quality, and housing could decrease the incidence of otitis media in children in the 
Northern areas of Canada (Orr, 2005).  Interventions that prevent host access of Candida 
albicans by creating an environment that does not support growth or development of 
virulence factors would also disrupt the potential for disease.  Soumpasis et al. (2015) 
used the epidemiologic triangle to evaluate the use of extended wear contact lenses, the 
host’s hygiene, and the risks associated with the development of opportunistic corneal 
infections with Pseudomonas aeruginosa.  Soumpasis et al. reported that there is 
significant overlap between the three components of the triangle, and intervention targets 
should be dependent upon whether the focus is epidemiologic investigations, risk 
assessments, or therapeutic treatments.  From an epidemiological perspective, the focus 
of an epidemiologic triangle model is to target disease transmission.  This includes 
factors in the host that increase susceptibility to disease, primary factors that promote the 
organism to cause disease, and proposed measures to control or reduce the incidence of 
disease (Soumpasis et al., 2015).  
Infections with Candida are thought to be caused by the organisms that naturally 
reside on or in the host.  Prevention of the formation of virulence factors in Candida 
albicans could reduce the risk of acquiring an infection from residing organisms (CDC, 
2013).  Other areas thought to act as a reservoir for Candida are fomites and hands of 
health care workers (Hota, 2004).  Candida albicans has been shown to survive on metal 




14 days; on human finger pads, 20% of the viable organisms remained detectable an hour 
after initial inoculation (Traore, Springthorpe, & Sattar, 2002).  The environment for 
Candida albicans can be on or in the host itself or merely on the inanimate environments 
that the host has contact with regularly.  Breaking the transference of the organism by 
disrupting the ability to survive in the host environment could disrupt the transmission of 
disease and prevent infections.  The way to interrupt this disease process is to decrease 
the likelihood of the organism from being transferred into new environments from 
infected or carrier hosts (Gupta & Khanna, 2014).  This type of transmission interruption 
could be used to study ways to prevent disease formation from Candida albicans in 
susceptible hosts.  Interventions that prevent host access of Candida albicans by creating 
an environment that does not support growth or development of virulence factors would 
also disrupt the potential for disease.    
Using a framework of the epidemiologic triangle for the research provided a 
foundation of an immunocompromised host, which can be placed into the susceptible 
host vertex, Candida albicans, which is placed at the agent vertex, and the environment 
which is at the third vertex of the triangle.  In this study, I investigated potential means to 
disrupt the triangular interaction by breaking one of the sides of the triangle that would 
prevent the disease formation.  In addition, the component relationships that enables 
disease to occur was also used for interpretation of the results from the study.  This 
potential to inhibit virulence factors could prevent the agent from entering and causing 
disease in the host.  Another potential place for disruption could involve prevention of the 




to decrease Candida albicans’s ability to cause disease by examining the prevention of 
virulence factor development and yeast cell inhibition or death as well as risk associated 
with the covariates age, gender, race, and comorbidities.   
Risk Factors Associated with Bloodstream Infections 
Yang et al. (2014) performed a retrospective analysis of the epidemiology of 121 
Candida bloodstream infections and determined that advanced age and neutropenia were 
independent risk factors for mortality within 28 days of initial occurrence of Candida 
bloodstream infections.  Over 95% of all patients with hospital acquired Candida sepsis 
between 2008 and 2012 had at least one comorbidity, and 56% of these patients had two 
or more comorbidities (Yang et al., 2014).  Although internal medicine wards had higher 
28-day mortality rates than surgical wards or intensive care units (ICU), Yang et al. did 
not further investigate this angle for infection but did comment that there was poor 
compliance to antifungal therapy in some of the wards.  Yang et al. also noted that 
appropriate antifungal treatment reduced the likelihood of patient death within the first 28 
days of infection.  Yang et al.’s research sample size and institution were comparable to 
this study’s sample size and type of hospital; however, the differences that may occur in 
United States hospitals have not been studied.  Inclusion of patient covariates such as age, 
gender, race, and comorbidities could add knowledge to the body of literature about risk 
factors for Candida albicans bloodstream infections.   
Kaye et al. (2011) examined 830 patients with bloodstream infections and 
compared them to 830 patients without bloodstream infections in the age group 69 to79 




obesity, and a central venous catheter present upon admission.  Other predictors included 
gastronomy, surgery, and previous hospital exposure (Kaye et al., 2011).  The 
predominant organism isolated through this study was Methicillin-resistant 
Staphylococcus aureus (MRSA), and additional interventions were suggested that would 
target elderly males (Kaye et al., 2011).  Although this research was used for overall 
bloodstream infections, not just Candida albicans infections, it can be used as a 
foundation to investigate whether the risk for Candida bloodstream infections are similar 
to other types of bloodstream infection risks. 
Shigemura et al. (2014) performed a retrospective study of 110 Candida 
bloodstream infections over a 5-year period.  Shigemura et al. determined that 
cardiovascular disease and having a recent surgery increased the risk of Candida albicans 
infections; however, chemotherapy and cancer increased the risk of Candida non-
albicans species.  In this study the majority (71%) of patients with Candida albicans 
bloodstream infections were male, but 62% of the septic patients were under the age of 
70 (Shigemura et al., 2014).  Hu et al. (2014) examined data of 294 patients and 
evaluated the potential risk factors for catheter-related Candida bloodstream infections 
(CRCBSI).  The risk factors were determined to be age and low body weight (Hu et al., 
2014).  However, in this study, Candida parapsilosis caused more CRCBSI and Candida 
albicans caused more non-CRCBSI (Hu et al., 2014).  Males accounted for the majority 
of these bloodstream infections with 75% of the CRCBSI and 68% of the non-CRCBSI 




highest (89.7%) in patients with CRCBSI, patients with non-CRCBSI had a CVC 
placement rate of 81.9% (Hu et al., 2014).   
Central-venous catheter placement was also found in 93% of patients with 
Candida bloodstream infections in a prospective study of 157 patients (Rajendran et al., 
2016).  Age was associated with increased mortality, and 47% of the 30-day mortalities 
were in patients with Candida albicans bloodstream infections (Rajendran et al., 2016).  
There was a higher mortality rate associated with Candida albicans than with Candida 
glabrata infections (Rajendran et al., 2016).  In addition, there was a higher mortality rate 
for patients whose Candida albicans isolates were shown in laboratory testing to be high 
biofilm formers than isolates that were shown to be low biofilm formers (Rajendran et al., 
2016).  Removal of a CVC after the detection of a Candida bloodstream infection 
improved the clinical outcome of the patient (Rajendran et al., 2016).  In a 6-month 
retrospective study of bloodstream infections from 2009 of 468 positive blood cultures, 
Chander, Singla, Sidhu, and Gombar (2013) showed that 5.79% were Candida isolates; 
however, in this study, the most common Candida recovered was Candida tropicalis.  
Candida bloodstream infections were associated with broad spectrum antibiotic use 
91.6% of the time and associated with CVCs 83% of the time.  These infections were 
nosocomial and occurred within 48 hours of admission (Chander et al., 2013).  Almost 
89% of candidemia were recovered from patients in the ICU (Chander et al., 2013).  ICU 
patients usually have failed host defenses due to underlying disease or an 
immunocompromised state (Chander et al., 2013).  Although these epidemiological 




factors were not as consistent throughout the studies.  This may be due to differences of 
predominant infections in various countries; however, additional studies used to examine 
risk factors for adult patients seen in the United States to provide additional means for 
reducing these factors in the high-risk patients.  This type of study may provide insight on 
protection measures that could also be used in immunocompromised patients.   
Immunocompromised Patients, Infections, and Prophylactic Treatments 
Immuno-competent hosts can respond to the invasive hyphal and psuedohyphal 
forms of Candida through pathogen recognition receptors (Lewis et al., 2012).  These 
receptors initiate adaptive immunity in the host that starts the inflammatory response to 
contain and destroy the invading organisms (Lewis et al., 2012).  However, when an 
immunocompromised host becomes infected with Candida, the ability of the host’s 
immune mechanisms to respond is diminished, and the potential for serious invasive 
infections increases (Lewis et al., 2012).  The increase of at-risk populations with life-
threatening fungal infections has also caused an increase in the fungus species that are 
considered pathogenic.  The most common invasive fungal diseases are caused by 
Aspergillus fumigatus and Candida albicans (Alcazar-Fuoli & Mellado, 2014).  
Complications to successful treatment include the difficulty in correctly identifying a 
fungal infection, as well as the increasing resistance of these organisms to antifungal 
medications (Alcazar-Fuoli & Mellado, 2014).  Although these types of infections can be 
difficult to manage due to the extended time it can take for antifungal medications to 
inhibit or kill the organism, there have been improvements in treatment methods and 




Candida species is complex, and additional information on how the immune system 
responds to these resistant organisms may provide improved understanding on the 
interactions of virulence factors and drug resistance (Lewis et al., 2012).  Providing 
alternative options that do not need host immune responses intact or treatments that do 
not depend on the same pathways into the yeast cells to disrupt virulence or cause cell 
death could enable better outcomes in high risk patients who are immunocompromised.  
Developing additional treatment options could minimize the impact of virulence and drug 
resistance in yeast cells. 
Virulence and Resistance 
Severity of Candida infections is correlated with higher virulence factors.  
Virulence factors in microorganisms can trigger immune responses in the host (Williams 
et al., 2013).  When Candida albicans did not produce virulence factors, infections were 
generally less severe and less likely to be invasive (Bliss et al., 2012).  Interruption of 
these virulence factors could improve patient outcomes (Bliss et al., 2012).  Virulence 
factors include germ tube or pseudo-hyphae production that helps the organism to invade 
the mucosal lining and establish the organism to withstand competition from normal flora 
inhabiting the mucosal membrane (Bliss et al., 2012).  This type of filamentous growth 
can be reversed back to unicellular forms based upon stress from the host environment, as 
well as the pH of the site of infection (Calderone & Fonzi, 2001).  Other virulence factors 
that increase pathogenicity of Candida albicans include biomolecules known as adhesins 
that are found on the yeast cells wall that promotes binding to the host cells (Calderone & 




proteases, which are enzymes that are needed for invasive disease development 
(Calderone & Fonzi, 2001).  These types of virulence factors can increase mortality rates 
by making the infectious process more severe and increasing the yeast cell ability to 
evade host responses (Bliss et al., 2012). 
Another key component for virulence is the production of biofilms.  Biofilms are 
communities of organisms that have adhered to a biological or inert surface and formed 
an extra-cellular matrix that hold the multi-cellular community together (Lopez, 
Vlamakis, & Kolter, 2010).  Candida albicans can be found in biofilms both as pseudo-
hyphal and hyphal forms; this combination of forms is thought to contribute to the 
development of Candida albicans biofilms as well as conferring increased resistance to 
antifungal medications (Watamoto et al., 2009).  Candida albicans biofilms have been 
shown to be up to 500 times more resistant to the polyene class of antifungals (such as 
amphotericin B) and the echinocandin antifungal drug, caspofungin, than high-density 
growth of planktonic (free floating, single cell type) cultures (Watamoto et al., 2009).  
This propensity for Candida albicans to produce biofilms increases the time that 
antifungal medications need to be taken and increases the chance that some of the 
organisms in the biofilm can develop resistance to the treatment and thus continue to 
replicate and survive in the host causing additional stress to the host systems (Watamoto 
et al., 2009).  Antifungal medication classes have different methods of inhibition and 
actions to destroy yeast cells.  Candida albicans survival mechanisms can inhibit these 
functions of the different antifungal drug mechanisms.  Exploring components to add to 




failures through prevention of the organisms’ resistance mechanisms.  The known modes 
of action of the classes of antifungal medications are discussed below. 
Amphotericin B has been shown to interact with the ergosterols in the yeast cell 
wall producing tiny channels that cause the potassium and magnesium to leak from the 
inside of the cell which then promotes the loss of the proton gradient of the cell wall 
(Watamoto et al., 2009).  In addition, the disruption of the ergosterol production prohibits 
the organism from developing hyphal forms thus reducing its virulence capabilities 
(Lewis et al., 2012).  Candida albicans biofilm researchers have suggested that the 
mechanism of maintaining membrane fluidity in mature biofilms relies less on ergosterol 
than younger biofilms and planktonic cultures which makes amphotericin B as well as the 
azole class of antifungal medications less effective for treatment of organisms from 
mature biofilms (Mukherjee, Chandra, Kuhn, & Ghannoum, 2003).  This type of 
resistance mechanism that changes the permeability of the cell membrane can reduce the 
ability for amphotericin B and fluconazole to enter the Candida cells thus causing 
treatment failure (Mukherjee et al., 2003). 
The echinocandin class of antifungal medications, including caspofungin, are 
fungicidal and inhibit the synthesis of a primary cell wall structural component, 1,3-β-D-
glucan (Bachmann et al., 2002).  Caspofungin has been shown to reduce the formation of 
Candida albicans biofilms as well as causing mutations and decreasing hyphal 
formations in established biofilms (Bachmann et al., 2002).  However, researchers from a 
multicenter surveillance program have indicated that recent exposure to caspofungin in 




minimum inhibitory concentration (MIC) to caspofungin in laboratory testing including 
isolates of Candida albicans and Candida tropicalis which both generally have lower 
MIC levels for caspofungin (Lotholary et al., 2011).  This increasing resistance to 
caspofungin, while still rare in Candida albicans, has caused researchers to focus on 
mechanisms in the organism that creates this resistance (Sanguinetti et al., 2015). 
The azole class of antifungal drugs (which includes fluconazole) inhibit mycelial 
growth by interrupting ergosterol biosynthesis which is a major component in the 
production of the plasma membrane of the cell (Ha & White, 1999).  Thus, the organism 
is more sensitive to azoles during the mycelial phase than the yeast phase due to the 
increased need of plasma membrane for hyphal growth during the mycelial phase (Ha & 
White, 1999).  Azole resistance in Candida albicans isolates can be caused by several 
mechanisms with the primary cause of resistance being contributed to drug efflux pump.  
Overexpression with other mechanisms such as altering the plasma membrane, changes 
to the synthesis of ergosterol, and drug uptake all possibly contribute to the decrease in 
susceptibilities of other antifungal medications (Cernicka & Subik, 2006).  Acquired 
amphotericin B resistance is thought to be caused by alterations in the production of 
ergosterol in the plasma membrane and by the organism’s ability to produce catalases 
which minimize oxidative damage caused by the antifungal medication (Lewis et al., 
2012).  Widespread prophylactic use of fluconazole has contributed to changes in the 
epidemiology of Candida infections invoking the selection of increasingly more resistant 
strains causing infections (Sanguinetti et al., 2015).  These types of acquired resistance 




Candida species resistance to echinocandins is generally associated with gene 
mutations of the 1,3-β-D-glucan synthase complex (Lewis et al., 2012).  However, the 
ability of echinocandins to expose β-glucans hidden underneath mannoproteins can still 
induce an immune response which during treatment, may prevent the emergence of 
subpopulations that acquire resistance (Lewis et al., 2012).  However, exposure to higher 
concentrations of echinocandins than the MIC level can cause Candida albicans to 
increase production of chitin and glucan which can cause an increase in tolerance to 
echinocandins which in turn could also inhibit the host’s immune response (Lewis et al., 
2012).  Kurtz et al., had previously concluded that these mutant strains of Candida 
albicans that are resistant to echinocandins are however, less virulent due to impairment 
of germ tube production (1996).  In addition, virulence can also be influenced by the 
utilization of different carbon sources by Candida albicans (Ene et al., 2012). 
Alternate carbon sources such as lactic acid can affect the cell wall synthesis, 
hydrophobicity, virulence, and resistance to antifungal treatments (Ene et al., 2012).  
Lactic acid can be found in various niches in the human body including the 
gastrointestinal and urogenital tracts through the body’s metabolic activity on ingested 
food and produced by bacteria commonly found in these areas (Ueno et al., 2011).  In 
laboratory testing, Candida albicans isolates grown on lactate media had a thinner cell 
wall with a marked decrease of chitin and β-glucan when compared to isolates grown on 
a glucose enriched media (Ene et al., 2012).  In addition, the lactate grown cell wall had a 
two-fold increase in porosity and showed a higher propensity to be hydrophobic than the 




exhibited a stronger adhesion to plastics than the isolates grown in the presence of 
glucose (Ene et al., 2012).  This ability to adhere is a virulence trait that has a major role 
not only in biofilm production on medical devices but also contributes to tissue 
colonization (Calderone & Fonzi, 2001).  In addition, lactate grown cells were more 
resistant to high salt concentrations and the cell walls were more rigid indicating an 
increased ability for the cells to penetrate the epithelial cells and establish pathogenic 
residency in the host (Ene et al., 2012).    
With the reduction of β-glucan and chitin in the thinner cell wall, lactate grown 
Candida albicans were more resistant to caspofungin and amphotericin B (Ene et al., 
2012).  Cells grown with glucose were more sensitive to amphotericin B and had less 
tolerance to osmotic stress compared to lactate grown cells (Ene et al., 2012).  Virulence 
factors can therefore also be affected by the carbon source (such as lactate or glucose) 
that is used by Candida albicans.  The carbon utilization pathway has been shown in 
mouse models to be dependent upon the site of infection and which carbon source is in 
higher abundance (Ene et al., 2012).  The immune system in an immunocompetent host 
contains additional antimicrobial fighting agents that can still respond to the invasion 
regardless of the location of the infection (Mehra et al., 2013).  Host defenses cannot 
respond adequately to infections when the immune system has been inhibited.  Healthy 
host defenses and integrative treatment options will be discussed in the next section. 
Alternative Treatment Options and Host Defenses 
Bacteria, fungus, and viruses can be directly killed through a component of the 




through immunomodulation or inhibiting virulence factors (Mehra et al., 2013).  AMPs 
can also synergistically interact with intact mucosal epithelial cells to prevent pathogenic 
invasions (Mehra et al., 2013).  The antifungal peptides have different microbial targets 
than antifungal medications which has caused investigators to study laboratory 
production of these AMPs as an alternative method for treating fungal infections (Mehra 
et al., 2013).  Topical treatments however appear to hold the most promising application, 
not systemic treatments therefore, other treatment options for systemic infections are still 
needed (Mehra et al., 2013).  Other researchers have targeted the potential use of 
defensins which are a specific group of AMPs found in a large majority of eukaryotic cell 
types (Silva, Goncalves, & Santos, 2014).  Defensins have antimicrobial properties but 
also can affect the functions of the immune system to protect the host from invading 
pathogens (Silva et al., 2014).  Defensins can attack the microbial cell wall and disrupt 
the activation of virulence factors (Silva et al., 2014).  While defensins can efficiently 
react to fungus and yeast, the serum half-life of these peptides is low and the treatment 
for invasive infections may also be limited (Silva et al., 2014).  In an 
immunocompromised patient, the body cannot produce enough AMPs and the technology 
to increase the ability for the defensins to be viable for treatment in yeast systemic 
infections remains elusive therefore other options still need to be investigated.  Even in 
immunocompromised patients however, the initial immune response starts with the 
epithelial cells. 
Host epithelial cells respond differently to commensal Candida compared to 




of defense against microorganisms and will respond differently to an organism based 
upon its production of virulence factors (Williams et al., 2013).  Organisms will produce 
these virulence factors as a method of survival (Williams et al., 2013).  Virulence factors 
trigger the host immune response and prevention of virulence factor production could 
prevent infections from occurring (Williams et al., 2013).  Additional protective defenses 
in the mucosal tissue of the upper and lower respiratory tract include antioxidant 
capabilities that can reduce pulmonary inflammation.  Enhancement of these protective 
mechanisms can also reduce tissue damage, immune responses, and the development of 
debilitating illnesses (Gao et al., 2011).  Without an adequate immune response, however, 
protection from severe infections is limited and the risk of environmental exposure and 
subsequent infections caused by Candida albicans somehow needs to be reduced.  
Different methods of investigating treatment options using various plant derived oils have 
been studied. 
Researchers utilized naturally occurring oils to strengthen the antioxidant and 
anti-inflammatory response in nasal mucosal epithelial cells of 12 healthy adults to 
evaluate a way to improve protection against infections in the lower airways (Gao et al., 
2011).  The combined mixture of aloe, orange, peppermint, coconut, and vitamin E, in a 
carrier oil of soy, reduced inflammation when volunteer test subjects were exposed to 
ozone (Gao et al., 2011).  The ozone was intended to mimic endotoxin production when 
an organism invades the mucosal membrane.  The authors extrapolated that the results 
could indicate that the combined oils could prevent infections from occurring by 




endotoxin production exposure (Gao et al., 2011).  While this research provides an 
interesting foundation for additional studies, the test sample was small, and the healthy 
adults may respond differently with ozone exposure than immunocompromised patients 
that are at an increased risk of severe infections.  
Other immune response mechanisms include the production of oxidative stress 
which has been shown to destroy microorganisms through the disintegration of the cell 
membrane (Khan et al., 2011).  Production of oxidative stress using the phenylpropanoid 
chemical compounds, estragole, methyl eugenol, and eugenol that are found in essential 
oils, substantially destroyed Candida albicans in laboratory testing (Khan et al., 2011).  
This type of oxidative stress is independent of the host immune response and could be 
useful for patients that are immunosuppressed.  While minimum inhibitory 
concentrations (MICs) of these compounds have previously been shown to disrupt 
membrane integrity and therefore cause fungal cell death, sub-MIC levels were also 
shown to severely damage the defense mechanisms of Candida albicans which ultimately 
also resulted in fungal cell death (Khan et al., 2011).  The potential for naturally 
occurring chemical compounds found in plants to be used as antifungal treatments that 
are not dependent on an intact immune system and do not interact with the areas targeted 
by antifungal drugs provides additional areas for research to improve patient health 
outcomes and reduce mortality risks.  Research involving interactions of various essential 






Essential Oil Treatments for Fungus and Yeast 
Fenugreek (Trigonella foenumgraecum), cinnamon (Cinnamomum verum), 
papaya (Carica papaya), oregano, and garlic all contain phytochemical compounds 
known to have anti-mycotic activity (Varadarajan, Narasimhan, Malaisamy, & 
Duraipandian, 2015).  Fenugreek, cinnamon, and papaya extracts were evaluated for 
activity against fluconazole resistant Candida albicans with zones of inhibition measured 
and the percentage of inhibition was then calculated (Varadarajan et al., 2015).  The 
MICs were calculated per standard protocol and all 3 extracts were shown to have anti-
mycotic activity with an MIC of 15.62 µg/ml (Varadarajan et al., 2015).  Several 
chemical compounds found in these extracts are known to inhibit proteins and enzymes 
that are essential for cell wall survival of both bacteria and fungus (Varadarajan et al., 
2015).  Other essential oils such as black cumin, curry, ajwain, and betel leaf were tested 
against Candida albicans, Candida tropicalis, Candida glabrata, and Candida 
parapsilosis (Rath & Mohapatra, 2015).  Ajwain and black cumin had the highest level of 
activity against the yeast by causing irreversible cell damage which led to subsequent cell 
death and the oils still maintained this activity after heat treatment and autoclaving (Rath 
& Mohapatra, 2015).  Mechanisms of membrane inhibition are thought to be caused by 
the ability of the oils to make partitions in the cell membrane which then causes the cell 
components to leak out and the organism to die (Rath & Mohapatra, 2015).  Various 
chemical compounds found naturally in essential oils are thought to be the agents 
responsible for the antimicrobial actions of essential oils (Bellete et al., 2012).  While 




plants specific to the researchers’ location, potential for widespread use could be limited.  
For this study, oregano, lemongrass, and thyme were chosen based upon not only 
previous research that has shown antifungal efficacy for all three oils, but also the 
widespread availability of the oils, which in turn could reduce the cost of adding the oils 
as treatment.  Lemongrass has been shown to also have strong anti-inflammatory 
properties (Boukhatem, Ferhat, Kameli, Saidi, & Kebir, 2014), which could potentially 
improve a patient’s well-being and comfort.  Specific chemical compounds for the 
essential oils in this study will be discussed in the next section. 
Chemical Composition and Mechanisms of Action of Lemongrass, Oregano, and 
Thyme Essential Oils 
The monoterpene aldehyde, citral, which is comprised of neral and geranial, is 
found in the highest concentration in lemongrass (Cymbopogon species) essential oil 
(Shah et al., 2011).  Other major components include the terpenes limonene and myrcene 
(Shah et al., 2011).  Citral, thymol, carvacrol, and linalool are all oxygenated terpenes 
which have been shown to effectively kill various microbes (Korenblum et al., 2013). 
These oxygenated terpenes are thought to produce oxidative stress on the yeast causing 
cell death (Khan et al., 2011).  The aldehydes are thought by some researchers to have 
more effective anti-microbial activity than the phenolic compounds such as thymol and 
carvacrol (Marin, Sanchis, & Ramos, 2011).  However, other authors have indicated that 
the phenols thymol, carvacrol, and eugenol have the highest antimicrobial activity due to 
containing an acidic hydroxyl group (Kalemba & Kunicka, 2003).  Aldehydes are also 




environment to a basic pH to induce virulence factors (Shah et al., 2011; Vylkova & 
Lorenz, 2014).  While there has been speculation that aflatoxins could be produced by 
certain fungus in relation to the increase in oxidative stress, the combination of phenols 
and aldehydes are thought to act synergistically and could provide alternatives that would 
be difficult for fungus and yeast to develop resistance or produce aflatoxins due to 
multiple fungi-toxic components (Molyneux, Mahoney, Kim, & Campbell, 2007; Sidhu, 
Chandra, & Behl, 2009). 
In oregano (Origanum vulgare) essential oil, the major constituents are also 
oxygenated monoterpenes, mainly carvacrol and thymol (Teixeira et al., 2013).  Pozzatti 
et.al, (2008) indicated that carvacrol along with thymol acts synergistically against 
Candida albicans and that fluconazole resistant strains appear to be highly susceptible to 
oregano.  Phenolic and terpene components have also been shown in the host to produce 
strong inhibition to pro-inflammatory mediators in such as nitric oxide and reactive 
oxygen species (Leyva-Lopez et al., 2016).  Nitric oxide (NO) and reactive oxygen 
species (ROS) can be utilized by the host to fight infections however, increased amounts 
of ROS can also destroy human cells (Brieger, Schiavone, Miller, & Krause, 2012).  ROS 
tends to transfer an electron to oxygen thus forming a superoxide which in turn can react 
with NO to create a highly reactive peroxynitrite (Brieger et al., 2012).  This 
peroxynitrite in turn has a high toxicity to human cells (Brieger et al., 2012).  Reducing 
these biochemical reactions from over stimulation could also help the immune system 
react to yeast infections more efficiently with less host damage (Leyva-Lopez et al., 




activity of combined essential oils (Tepe, Daferera, Sokmen, Polissiou, & Sokmen, 
2004). 
Like oregano, thyme (Thymus vulagris L.) essential oil also is primarily composed 
of the phenolic compounds, thymol and carvacrol (Agili, 2014).  Thyme essential oil is 
acidic with a pH around a 3.5 (Agili, 2014).  An acidic environment inhibits the ability of 
Candida albicans to switch to the more virulent hyphal phase (Vylkova & Lorenz, 2014). 
Thymols constitutes generally around 50% of the compounds in thyme and carvacrol 
makes close to 5% of the components (Agili, 2014).  Thymol and carvacrol have shown 
synergistic anti-microbial effects when combined in laboratory experiments (Tepe et al., 
2004).  Researchers have speculated that the essential oil activity against microbes may 
be due to the ratio of the chemical components, not merely by the quantity found in the 
essential oil (Kalemba & Kunicka, 2003).  This information provides a foundation to 
study the use of lemongrass, oregano, and thyme individually and combined for improved 
efficacy against Candida albicans isolates.  Research on lemongrass, oregano, and thyme 
essential oil activity against fungus and yeast will be addressed in the following section. 
Activity of Essential Oils Against Yeast and Fungus 
While carvacrol can make up 90% of the compounds found in oregano, authors 
have indicated that purified constituents at equal concentrations are less effective against 
microbes than the original essential oil indicating that the components act synergistically 
even in small quantities (Turgis, Han, Caillet, & Lacroix, 2009).  This could prevent the 
development of antifungal treatments with synthetically developed chemical compounds 




conditioner is used to promote healing around dental devices however, the conditioner 
can become a reservoir for microorganisms including Candida after extended use 
(Amornvit et al., 2014).  Lemongrass essential oil and nystatin were each mixed with the 
tissue conditioner and tested against 10 clinical Candida isolates as well as a quality 
control strain (Amornvit et al., 2014).  The lemongrass had a calculated MIC level of 
0.635 µ/ml but to achieve effectiveness mixed in with the tissue conditioner, a 0.25% 
volume, calculated at 4-times the MIC level, was needed due to the viscosity of the tissue 
conditioner.  Lemongrass was similar to nystatin in efficacy against the Candida strains 
tested (Amornvit et al., 2014). 
Researchers also investigated the antifungal activities of lemongrass in the 
laboratory as well as its anti-inflammatory properties in mice (Boukhatem, Ferhat, 
Kameli, Saidi, & Kebir, 2014).  The quick acting anti-inflammatory properties of 
lemongrass were demonstrated in mice through both topical and oral application 
(Boukhatem et al., 2014).  The antifungal properties were assessed both in liquid and 
vapor phases (Boukhatem et al., 2014).  While both phases inhibited fungal isolates, the 
vapor phase showed increased efficacy against the fungal isolates and Candida albicans.  
This may provide a basis for further studies using different methods of delivery of 
essential oil treatments.  Lemongrass has been shown to disrupt biofilm formation in 
Candida albicans isolates that were known to be able to produce moderate to strong 
biofilms and the researchers were unable to increase tolerance to lemongrass by exposing 
the Candida albicans isolates to low levels of the essential oil (Sajjad Ahmad Khan & 




further study the use of essential oils against Candida since resistance to the antifungal 
medications continues to increase. 
Thyme was also evaluated to examine antifungal activities against Candida 
albicans and Aspergillus fumigatus (Bellete et al., 2012).  Thyme essential oil showed 
strong antifungal activity in low concentrations (Bellete et al., 2012).  To confirm that 
this activity was due to chemical compounds in the oil and not just the use of any oil, 
vegetable oil and three additional essential oils (vetiver, wild orange, and argan) with 
known minimal antifungal activity were also tested.  Increased dilutions of the organisms 
were still inhibited with the introduction of thyme (Bellete et al., 2012).  Low 
concentrations of essential oils needed for antimicrobial activity and the volatile nature of 
essential oils provide additional areas for research (Bellete et al., 2012).  Additional 
researchers compared the activity of cinnamon, lemon, eucalyptus, and thyme compared 
to activity of chloramphenicol against Candida albicans, Tricophyton, and Microsporum, 
and several bacterial strains (Nasir, Tafess, & Abate, 2015).  Thyme had the largest zone 
of inhibition upon laboratory testing (Nasir et al., 2015).   
Thyme has potential to be used in topical treatment of dermatophytes as well as 
other fungal, yeast, and bacterial isolates.  Calculated MIC levels were shown to be lower 
for thyme than levels needed for chloramphenicol (Nasir et al., 2015).  In addition, the 
zone of inhibition for thyme against the organisms tested was almost twice as large as the 
zone for chloramphenicol (Nasir et al., 2015).  Other studies where researchers compared 
essential oil activity against Candida species in comparison to amphotericin B and 




Candida species than lemon or pennyroyal essential oil (Omran & Esmailzadeh, 2009).  
While amphotericin B had a larger zone of inhibition in this study than fluconazole, 
thyme exhibited a larger zone of inhibition than either antifungal medication tested 
(Omran & Esmailzadeh, 2009).  Researchers do admit however, that zone size 
comparisons can be difficult to determine rates of effectiveness and further evaluations 
are warranted (Omran & Esmailzadeh, 2009).  Time-to-kill assays proposed in this study 
may provide a more accurate assessment of essential oil activity against Candida 
albicans. 
While the focus of multiple studies has been on antimicrobial activities of 
essential oils other researchers have examined mechanisms of how the essential oils 
cause damage and pathogen cell death.  Rajkowska, Kunicka-Stycynska, Maroszynska, 
and Dabrowska (2014) evaluated the effect that tea tree and thyme essential oils had on 
biochemical and enzymatic processes of Candida albicans strains.  Extensive loss of the 
ability to assimilate different carbon sources occurred in Candida albicans isolates after 
exposure to tea tree and thyme essential oils (Rajkowska et al., 2014).  This disruption in 
enzymatic activity could decrease the pathogenesis of Candida albicans (Rajkowska et 
al., 2014).  Thyme and tea tree essential oil have also been shown to not only reduce the 
activity of enzymes but the ability for Candida to uptake sugars was also inhibited or 
prevented (Rajkowska et al., 2014).  Monoterpenes such as carvacrol and thymol are 
thought to disrupt ATP synthesis reducing regulation of other cellular functions 
(Custodio, Ribeiro, Silva, Machado, & Sousa, 2011).  Other researchers have also 




oils in laboratory testing (Budzynska et al., 2013).  This inability to develop resistance 
could provide additional options for long-term prophylactic use of essential oils to 
prevent Candida infections in immunocompromised patients and potentially reduce the 
number of drug-resistant Candida in the host environment and therefore improve patient 
outcomes and reduce hospitalizations and mortality.  In addition, various essential oils are 
quick-acting fungicides that have been shown to decrease the ability of Candida albicans 
to withstand oxidative stress from the immune system (Budzynska et al., 2013).  This 
aspect could also benefit immune-competent patients.  Other investigations have been 
used to evaluate the interactions between essential oils and antimicrobial treatments 
which will be discussed in the following section. 
Effects of Combining Antimicrobials and Essential Oils  
A total of 35 combinations of various essential oils and antibiotics were tested 
against three strains of Escherichia coli with four combinations showing high synergistic 
effects (Xi Yap, Lim, Hu, & Yiap, 2013).  The combinations with the highest effects 
were piperacillin/cinnamon, piperacillin/lavender, piperacillin/peppermint, and 
meropenem/peppermint (Xi Yap et al., 2013).  These combinations could allow for a 
reduction in the effective dose of the antibiotics needed which in turn, could decrease the 
adverse side-effects of antibiotic treatment (Xi Yap et al., 2013).  There were also no 
antagonistic effects observed between the essential oils and antibiotics tested, which 
would indicate that essential oils do not lessen the effect of the antibiotics and the 
antibiotics do not interfere with the effect of the essential oils (Xi Yap et al., 2013).  In 




that possess plasmid mediated resistance to the antibiotic (Xi Yap et al., 2013).  Further 
investigations into interactions between antifungal medications and multiple essential oils 
have not been extensively studied.  Increased resistance to antifungal medications as well 
as increased fungal infections due to Candida albicans has also created the need for 
researchers to find potential alternative treatment options (Sajjad Ahmad Khan et al., 
2012).   
Researchers screened 21 essential oils for activity against drug resistant strains of 
Candida albicans (Sajjad Ahmad Khan et al., 2012).  Lemongrass exhibited strong 
antifungal activity and appeared to be more effective than fluconazole against Candida 
isolates tested (Sajjad Ahmad Khan et al., 2012).  The eugenol compounds found in clove 
oil exhibited high levels of synergy with fluconazole and amphotericin B against drug 
resistant yeast strains (Sajjad Ahmad Khan et al., 2012).  Eugenol is a phenylpropanoid 
and has similar properties to the phenols thymol and carvacrol which are found in 
oregano and thyme. Pozatti et al., (2008), concluded that oregano, thyme, ginger, and 
cinnamon all express antifungal activities on both fluconazole sensitive and resistant 
strains of Candida species.  Oregano showed the highest activity against fluconazole 
resistant and susceptible strains of Candida which led the authors to suggest that the 
antifungal activity of oregano is not dependent upon changes in Candida that are 
associated with fluconazole resistance (Pozatti et al., 2008).  Due to the higher activity of 
oregano compared to thyme, the authors concluded that carvacrol could be the main 
constituent responsible for the antifungal activity (Pozatti et al., 2008).  In comparison, 




to thyme than the fluconazole sensitive counterparts which the authors concluded may be 
due to the combined activity of the chemical compounds found in the oils tested or that 
the resistance mechanisms could make the organisms more susceptible to the impact of 
the essential oils (Pozatti et al., 2008).  Other studies on various thyme species have led 
researchers to conclude thyme essential oils showed a stronger synergy with fluconazole 
than amphotericin B against Candida species (Saad et al., 2010).   
While tea tree oil and its chemical components were tested against 100 Candida 
isolates and shown to be effective against biofilm forming strains (Ramage et al., 2012), 
additional researchers investigating the activity of lemongrass essential oil against the 
formation and reduction of pre-formed Candida biofilms have also indicated that while 
these laboratory-created biofilms have shown increased resistance to antifungal drugs, the 
biofilms displayed no tolerance to lemongrass (Sajjad Ahmad Khan & Ahmad, 2012).  
Cancer patients are at increased risk of oral Candida infections due to the formation of 
these biofilms which then increases the risk of invasive infections (Ramage et al., 2012).  
Utilizing lemongrass to reduce oral biofilms could interrupt the reservoir for invasive 
infections of Candida and disrupt the epidemiologic triangle.  Lemongrass was also 
shown to cause deformities in the 3-dimensional structures of the biofilms, even at sub-
MIC levels (Sajjad Ahmad Khan & Ahmad, 2012).  In addition, there was a 60% 
reduction of viable sessile cells of Candida within 12 hours of exposure to lemongrass 
but not with fluconazole or amphotericin B even after 48 hours (Sajjad Ahmad Khan & 
Ahmad, 2012).  The authors concluded that the ability for lemongrass to prevent biofilm 




toxicity load to the patient (Sajjad Ahmad Khan & Ahmad, 2012).  Reduction of toxicity 
of antifungal medications to improve patient outcomes has previously been discussed 
however, questions about potential of toxicity of essential oils to human cells will be 
discussed in the next section. 
Evaluation of Host Cell Toxicity from Essential Oils 
A potential concern for utilizing essential oils for treatment in patients is whether 
the essential oils are also toxic to human cells.  Agili (2014) investigated the effects of 
thyme on three types of cancer cells lines as well as a non-tumor human cell line grown 
in the laboratory.  While the thyme inhibited the tumor cell growth by 50%, the essential 
oil had no cytotoxic effect on the non-tumor cell line PLP2 even at concentrations higher 
than 450 µg/ml (Agili, 2014).  Sinha, Jothiramajayam, Ghosh, & Mukherjee (2014) 
evaluated the potential toxic effects of lemongrass, palmarosa, citronella, and vetiver 
against human lymphocytes in cell cultures.  The authors reported that while the essential 
oils tested were cytotoxic at 1000 µg/ml, this is over 100 times the amount needed to 
have an antifungal effect on yeast and fungus (Sinha et al., 2014).  The MIC range for 
essential oils to kill yeast and fungus is normally between 0.2 and 10 µg/ml (Sinha et al., 
2014).  The authors concluded that lemongrass, palmorosa, citronella, and vetiver would 
be safe for human consumption at lower levels (Sinha et al., 2014).  The essential oils in 
the Sinha et al. (2014) study were purchased through Sigma-Aldrich Chemical which 
may not provide high quality naturally derived plant oils and could therefore limit the 




Variances in study designs and essential oils tested were not always evaluated 
using standardized methods.  For example, some researchers distilled the essential oils 
from dried plant material stored at various temperatures for various lengths of time 
(Agili, 2014; Bellete et al., 2012; Boukhatem et al.; 2014; Cleff et al.; 2010; Teixeira et 
al., 2013) and others purchased oils or chemical compounds from a vendor (Omran & 
Esmailzadeh, 2009; Pozatti et al.; 2008; Rajkowska et al.; 2014, Sajjad Ahmad Khan et 
al., 2012;  Xi Yap et al., 2013).  With the variety of distilling techniques and storage 
stability used in the reviewed research, there could be a potential to not be able to 
reproduce the results that were reported or for similar research to publish different results 
on the effectiveness of different essential oils against Candida isolates.  To minimize 
result errors due to inconsistencies in the quality of the essential oils tested, the essential 
oils used for this research were all purchased from a known high-quality vendor, 
doTERRA International.  Each batch of essential oils are tested using gas 
chromatography and mass spectrometry to evaluate the chemical compounds found in 
each oil.  In addition, the oils are further tested using Fourier Transform Infrared 
Spectroscopy (FTIS) to ensure potency and consistency between each batch, chirality 
testing which verifies that there are no synthetic components found in the oils, heavy 
metal testing to ensure there are none present, and microbial testing to verify there is no 
contamination of bacteria, fungus, or viruses (doTERRA CPTG Certified Pure 
Therapeutic Grade Quality Testing website, 2016).  The chemical components from each 
oil tested will be provided by the vendor to improve comparability with previous test 




well as combined essential oils with antifungal medications.  This research also provided 
a foundation and direction for additional research.  Further information concerning the 
methods employed in the reviewed articles are discussed in the next section. 
Methodology Review 
Increased drug resistance of fungus, yeast, and bacteria due to higher numbers of 
immunocompromised patients who are at high-risk for infection, have caused researchers 
to investigate potential alternative treatment options.  Candida albicans is the second 
leading cause of fungal infections worldwide and this disease burden is likely 
underestimated due to misdiagnosis and lack of required reporting for all invasive fungal 
disease except for Coccidioides which causes Valley Fever (Brown et al., 2012).  Most 
studies reviewed used a quasi-experimental design not an experimental design due to lack 
of randomizing the organisms studied (Amornvit et al., 2014; Bellete et al., 2012; 
Boukhatem et al., 2014; Gao et al., 2011; Khan et al., 2011; Lewis et al., 2012).  Most of 
the research reviewed were performed primarily in laboratory-controlled settings.  
Several of the studies were case reports based on infectious disease outcomes when 
patients were infected with Candida (Alcazar-Fuoli & Mellado, 2014; Brown et al., 
2012).  Other research methods were a combination of case reports of patient outcomes 
and using organisms isolated from patient infections in experimental laboratory testing 
(Bliss et al., 2012).  This section is used to review the methodology that was used to 
evaluate essential oils, antifungal medications and the interactions with various 




Several of the studies performed used novel approaches to test interactions and 
some studies had very detailed methodology that could easily be expanded upon for 
future research (Omran & Esmailzadeh, 2009; Rajkowska et al., 2014; Sajjad Ahmad 
Khan & Ahmad, 2012).  Some researchers attempted to address in-vivo issues using 
human cell lines and mouse models (Ramage et al., 2012; Sajjad Ahmad Khan et al., 
2012).  One study had human participants to study the ability of reducing nasal passage 
inflammation after ozone exposure using essential oils however, this study was small and 
used healthy individuals (Gao et al., 2011).  All the experimental studies either had 
replicated sample testing multiple times or had large sample sizes to protect validity and 
reliability. 
Evaluation of the potential covariates and risk factors were done using 
retrospective studies (Chander et al., 2013; Shigemura et al., 2014; Yang et al., 2014), a 
retrospective case-control study (Kaye et al., 2011), and prospective studies (Hu et al., 
2014; Rajendran et al., 2016).  The researchers in these studies reported on different risk 
factors or predictors but other information could also be acquired about some of the 
patient demographics however, race as a covariate was not discussed in any of the articles 
mentioned.  Race has previously been shown to be a factor in other health risks (Frieden, 
2011) therefore, the inclusion of race in evaluating risk factors for Candida albicans 
bloodstream infections may provide additional insight for prevention measures.  The 







Increased numbers of long-term immunocompromised patients provide ample 
environments for opportunistic pathogens to infect patients and for well recognized 
pathogens to acquire higher levels of drug resistance.  With limited anti-microbial 
medications available, acquired drug resistance especially in yeast such as Candida 
require new and different approaches to successfully treat these patients (Silva et al., 
2014).   
Novel options such as synthesis of naturally occurring antimicrobial proteins 
(AMPs) provide an exciting potential for treatment however, the short half-life of the 
proteins pose potential delivery issues in the patient as well as stability of the proteins to 
maintain efficacy while being stored or manufactured (Mehra et al., 2013).  Candida 
albicans produce virulence factors that disrupt the mucosal epithelial surfaces which can 
allow for the yeast to create serious and life-threatening infections (Lewis et al., 2012).  
Preventing these virulence factors from forming could also improve patient outcomes and 
reduce the risk of serious infections (Bliss et al., 2012).  Alternative options for treatment 
of Candida infections include the investigations of utilizing antimicrobial peptides 
(AMPs) for interrupting the disease process (Mehra et al., 2013).  While AMPs show 
promise at being able to kill various microorganisms, the half-life is very limited in 
serum and these treatment options may not prove beneficial for invasive infections (Silva 
et al., 2014).  One type of AMP, known as defensins, have also shown promise to reduce 




however, the ability to get the defensins to the infection site may prevent widespread use 
other than topical treatments (Silva et al., 2014). 
Virulence factors in microorganisms can trigger immune responses (Williams et 
al., 2013).  Pathogen recognition receptors (PRR) can initiate immune responses to 
invading yeast.  Immune defenses can also include antioxidant activity in the mucosal 
tissues.  Essential oils can increase antioxidants that are responsible for the reduction of 
pro-inflammatory toxins released by microorganisms that cause infections (Gao et al., 
2011).  Phenylpropanoid compounds found in various essential oils destroy Candida 
through oxidative stress and subsequent cell wall destruction in laboratory testing (Khan 
et al., 2011).  Extracts of fenugreek, cinnamon, and papaya have all shown anti-mycotic 
activity by inhibiting proteins and enzymes needed for cell wall survival in bacteria and 
fungus (Varadarajan et al., 2015).  In addition, other research has shown that tea tree oil 
can not only prevent biofilms caused by Candida isolates but also reduce inflammatory 
response in host tissue (Ramage et al., 2012).  Black cumin, curry, ajwan, and betel leaf 
showed strong activity against various Candida species by causing irreversible cell 
damage which in turn caused cell components to leak out.  These essential oils also 
maintained effectiveness after heat treatment and autoclaving (Rath & Mohapatra, 2015).  
While many essential oils have been evaluated as alternative treatment options, some are 
only available at a local level, are expensive to manufacture, or would not be available in 
larger amounts on a regular basis.  Therefore, lemongrass, oregano, and thyme were 




Lemongrass essential oil treatment showed similar efficacy against Candida when 
compared to nystatin treatment of tissue conditioners that are used to promote healing 
after dental procedures (Amornvit et al., 2014).  Additional studies were used to assess 
antifungal properties of lemongrass in both liquid and vapor phases as well as potential 
anti-inflammatory properties.  The anti-inflammatory treatment was quick acting in mice 
and the vapor phase showed higher efficacy against Candida albicans and fungal isolates 
(Boukhatem et al., 2014).   
Thyme essential oil has also been shown to have strong antifungal activity in low 
doses against Candida isolates (Bellete et al., 2012).  In comparison of cinnamon, lemon, 
eucalyptus, and thyme to chloramphenicol against yeast colonies, thyme had increased 
zones of inhibition and lower MIC levels were needed for inhibition of the organisms 
tested (Nasir et al., 2015).  Utilizing a combination of 35 various essential oils and 
antibiotics, additional researchers tested these combinations against resistant strains of 
Escherichia coli (E. coli).  Four of these combinations had high synergistic effects 
against E. coli.  These combinations could reduce the amounts of antibiotics needed to 
treat infections (Xi Yap et al., 2013).  This information could be used to develop 
additional studies for treatments against Candida albicans infections.  Drug resistant 
Candida albicans were also tested against 21 essential oils.  Lemongrass exhibited high 
antifungal activity and was more effective than fluconazole against these resistant strains 
in laboratory testing (Sajjad Ahmad Khan et al., 2012). 
Essential oils have been used in remedies for centuries and researchers from all 




using a variety of essential oils against a multitude of organisms in laboratory testing.  
Essential oils such as oregano, lemongrass, and thyme have been shown to have 
inhibition and cidal capabilities against Candida isolates (Boukhatem et al., 2014).  
Added benefits of potential essential oil use for infections are the capabilities for the oils 
to reduce inflammation (Ramage et al., 2012). 
While it may be difficult to study only essential oil interactions with Candida 
infections in human subjects due to a risk for the patient in deviating from standard of 
care, the addition of essential oils to standard antifungal treatment methods might prove 
to be a successful alternative.  The pursuit of evaluating host interactions with essential 
oil treatments for infections may be enhanced by additional studies of synergistic 





Chapter 3: Research Method 
Introduction 
The purpose of this study was to develop a system to examine the effectiveness of 
three individual essential oils (lemongrass, oregano, and thyme) used separately and in 
conjunction with each other in the presence of the antifungal medications fluconazole and 
caspofungin.  These antifungal treatments are recommended for a patient with a Candida 
albicans systemic infection (Pappas et al., 2016).  A quantitative method was used to 
evaluate the impact the use of these oils in combination with antifungal medications had 
on the ability to minimize virulence factors and to kill Candida albicans in-vitro. 
Repeated and long-term use of antifungal medications has helped to develop 
increased resistance to these medications in Candida species (Mehra et al., 2013).  This 
increased drug resistance has not only elevated the cost for treatment, but also has 
increased the risk of mortality from these infections.  Limited treatment options and 
rising mortality rates in both adults and children infected with Candida necessitates new 
methods for treating these life-threatening infections (Zaoutis et al., 2005).   
In this chapter, I will review the research design and rationale for using a 
quantitative method to examine the interactions of the essential oils lemongrass, oregano, 
and thyme with antifungal medications and the impact on known virulence factors of 
Candida albicans.  The study participants, sampling, study variables, and measurements 
used will also be discussed in this chapter.  This will be followed by the statistical 
analysis methods, as well as the potential ethical concerns of using data obtained from 




Research Design and Rationale 
I used a quantitative design to evaluate the impact these oils in combination with 
antifungal medications had on the ability to interfere with virulence factors of Candida 
albicans; the ability to cause death to the yeast cells; and to evaluate the impact of age, 
race, gender, and comorbidities on the risk of Candida albicans bloodstream infections.  
Quantitative experimental designs are used to test a cause and effect relationship with 
known variables (Frankfort-Nachmias & Nachmias, 2007).  The research questions of 
whether essential oil treatment can have a positive impact on Candida albicans infections 
were best investigated by using a quantitative experimental design.  This experiment was 
further designed to evaluate the covariates for confounding and risk factors.  Using an 
experimental quantitative design also enables the researchers to replicate the study to 
verify the results or for additional researchers to repeat the study to determine whether 
the outcomes are similar (Frankfort-Nachmias & Nachmias, 2007). 
For an organism to cause an infection, it must produce virulence factors and 
continue to replicate.  Antifungal medications attack the organism by various means to 
kill the organism or prevent replication of the organism (CDC MASTER website, n.d.).  
This process can take an extended amount of time, and the organism may become 
resistant to the medication during that time (Bliss et al., 2012).  Essential oils have been 
shown in previous laboratory studies to stop the organism from producing these virulence 
factors, as well as killing these infectious organisms (Cleff et al., 2010).   
I investigated the effectiveness of essential oils against Candida infections, as 




deductive methodology to provide alternatives for these resistant organisms.  Data were 
collected on whether the organism was inhibited or killed using repeat culturing methods 
for the organism, as well as investigating any statistical significance based upon the 
covariates. 
The experimental design allowed for this research to be replicated with additional 
population groups or by other researchers (Frankfort-Nachmias & Nachmias, 2007).  Use 
of this design can also provide a way to assure a high degree of validity due to the ability 
to culture each Candida albicans isolate before and after exposure to the essential oils 
and antifungal medications, as well as determining whether any of the covariates are 
related to increased yeast.  Although current researchers provided promising in-vitro 
results of the efficacy of essential oils against Candida and its infectious properties, there 
are limited treatment options used for Candida infections when the organism has become 
resistant to multiple medications (Tyagi & Malik, 2010).  With the continued increase in 
drug resistance, there have been few published studies aimed at validating the response in 
isolates collected from patients in populations being exposed to alternative treatment 
regimens.  Scholars have investigated different essential oils and their effectiveness 
against Candida using various methods to monitor levels needed to inhibit or kill the 
yeast cells; however, there has been no standardized testing within a population of 
infected patients.  This has made it difficult to determine the true effectiveness of 
essential oils against Candida infections.   
The variables measured in the first five research questions of this study included 




independent variable of treatment.  These eight levels included treatment with the 
individual essential oils lemongrass, oregano, and thyme, individual treatment of the 
antifungal medications fluconazole and caspofungin, the combined treatment of the three 
essential oils, the combined treatment of the three essential oils with fluconazole, and the 
combined treatment of the three essential oils with caspofungin.  The sixth research 
question had a dependent variable of inhibition of germ tube production with the 
independent variable of treatment with three levels.  These three levels of treatment were 
the three combined essential oils, fluconazole, and caspofungin.  The ability to measure 
these treatment outcomes also allowed me to ascertain whether there was a causal effect 
of the various treatments studied.  The last research question had independent variables of 





The population for this study were adult patients (18-74 years of age) at a large 
teaching hospital who have had at least one positive blood culture with Candida albicans 
recovered within the past 7 years.  Isolates recovered from blood cultures were cryo-
preserved at -80º centigrade.  Isolates were stored from the previous 7 years, and patient 
demographics were also available for this timeframe.  Blood cultures with multiple 
organisms isolated were not included, and only the information from the initial isolate of 




albicans isolated from a blood culture were included regardless of the length of stay.  
This population consisted of patients of various age, gender, race, and comorbidities. 
Sampling and Sampling Procedures 
The sampling techniques can be either a nonprobability method, which have a low 
generalizability, or a probability method, which can be generalized to the population with 
a higher degree (Burkholder, n.d.).  In this study, the method used could be considered to 
have a low generalizability to the population at large but a high generalizability  to the 
population  receiving antifungal medications for Candida infections (Crosby, 
DiClemente, & Salazar, 2013).  Using a sample strategy that can be generalized to the 
population at large would not be feasible due to the purpose of studying isolates 
recovered from bloodstream infections that may be immunocompromised patients, while 
the general population will include people who are immunocompetent and are less likely 
to have Candida albicans bloodstream infections.  However, further studies could 
provide additional information outside of the hospitalized, potentially 
immunocompromised population. 
A stratified sample was also used in this research to divide the sample frame into 
subpopulations.  Variables for stratification include age, gender, and race (Crosby et al., 
2013).  For this study, the sampling population was all-aged adults, gender, race, and 
comorbidities seen at this large teaching hospital.  The hospital internal review board 
(IRB) approved data collection for patient covariates to be obtained using access to the 
electronic health records (EHR) of patients who have previously been identified as 




microbiology department.  The data were logged into a spread sheet with only age group, 
race, gender, and comorbidities.  In defining comorbidities for epidemiologic studies, 
Yang et al. (2014) cited organ tumors, hematologic malignancy, diabetes, chronic 
pulmonary disease, renal failure, and cardiac disease as the primary comorbidities.  Hu et 
al. (2014) reported that the main comorbidities included diabetes, solid tumor cancer, 
hematologic malignancy, cardiac, renal, or hepatic failures, as well as 
immunosuppression.  Shigemura et al. (2014) listed diabetes, cancer, cardiovascular, 
renal, and liver diseases as the main comorbidities in reporting on 110 cases of Candida 
bloodstream infections.  Although Kaye et al. (2011) also noted diabetes, metastatic 
malignancy, and chronic pulmonary or heart disease, HIV was also listed as a 
comorbidity in the 830 cases of blood stream infections from any type of organism.  
Based upon the reviewed epidemiologic reports, and the variety of patients who were 
seen at the hospital where the data were collected, the comorbidities that were evaluated 
included diabetes, kidney failure, organ transplant, stem cell transplant, solid organ tumor 
cancer, positive HIV status, hematological malignancy, substance abuse, abdominal 
surgery, severe burns, other types of surgery, soft tissue cancer, autoimmune disorder, 
and multiple organ failures.  To compare covariates of a noninfected control group to the 
covariates of patients with Candida albicans blood stream infections, an aggregated 
sample of patient demographics and comorbidities were collected for the same period, 
and a randomized sample of 120 patients were pulled from the EHR using a research 
randomizer program (Research Randomizer, n.d.).  There were no patient identifiers 




patients, the age groups were divided as 18-24, 25-34, 35-44, 45-54, 55-59, 60-64, and 
65-74.  Age groups were separated into divisions used by the United States Census 
Bureau (n.d.) because investigating epidemiology of bloodstream infections has referred 
to mean age, not age groups (Hu et al., 2014; Kaye et al., 2011; Shigemura et al., 2014; 
Yang et al., 2014).  The hospital required a full IRB approval for data collected on 
patients 75 years and older therefore data were chosen to be collected on adults under the 
age restriction (University of Colorado Health [UCH], n.d.).  Sample size affects the 
statistical significance (p value), and a larger sample size of 100 patients or more is 
preferred.  The sample size was dependent upon the number of isolates recovered and 
frozen in the previous 9 years.  Initial Candida albicans isolates were found by reviewing 
the positive blood culture patient log stored in the microbiology department’s records.  
These log forms had minimal patient demographics, and the additional covariate 
information were accessed through the EPIC medical records system and documented 
without patient names on a spreadsheet that lists organisms as arbitrary numbers.  The 
patient’s data were initially sorted by age due to the normal decrease of the immune 
response of healthy, elderly patients (Wanke et al., 2000).  The sample size was based 
upon the number of isolates of Candida albicans recovered and saved from 2009 through 
August 2017 that met the criteria including whether all the patient covariates were 
available.  Immunocompromised patients who received bone marrow transplants had an 
11.4% risk of developing invasive Candida infections (Goodrich et al., 1991).  A 
G*Power analysis calculated that with a power (1-β) =1.0 and an α err of 0.05, the total 




This was calculated using an ANOVA repeated measures, within between factors test 
comparing eight groups and 10 measurements.  This calculation was used to assess the 
first six research questions.  Using a G*Power analysis for logistic regression, the total 
sample size for the patient demographics of 220, the power (1-β err prob) = 0.992. 
Data Collection Procedure 
The data collected from each patient listed age, gender, race, and comorbidities.  
Data was also collected on the growth response of Candida albicans in the presence of 
individual essential oils and the oils combined, and growth response of the organism to 
the combined use of essential oils and antifungal medications.  Data collected from 
culture growth included the amount of growth at each time interval tested for each test 
treatment at 24 and 48 hours of incubation, and whether each treatment inhibited the 
germ tube production of each organism tested.   
The patient data was de-identified and stored as isolate numbers only with gender, 
race, age range, and co-morbidities listed on a password protected portable drive.  This 
information has been kept in a private office with limited access.  The data will be 
compiled and presented at Infectious Disease rounds and at an annual conference on 
essential oil uses.   
Instrumentation and Scale 
To investigate the efficacy of treatment with essential oils in combination with 
prescribed antifungal medications on the time to kill Candida albicans recovered from 
hospitalized patients, an interval scale was used to determine the number of hours that the 




germ tube inhibition.  An interval scale was used to measure the distance between 
variables but cannot be used to determine a ratio (Kimberlin & Winterstein, 2008).  The 
interval scale for this study measured the time it took for the organism to be killed with 
the essential oil treatment compared to standard treatment, and the combined treatment.  
The level of measurement was chosen as a measure of the time until the organism was 
dead.  A ratio level was used to compare the kill rates of the antifungal treatment with the 
essential oil treatment.  A ratio scale was used to determine order, quantitate any 
differences between the values, and to calculate ratios (Kimberlin & Winterstein, 2008).   
Testing a patient for cure from a Candida infection, is done by culturing 
specimens collected from the site of the patient’s infection and quantitating any growth of 
Candida that occurs (Clinical Laboratory Standards Institute, n.d.).  Essential oils have 
been shown to reduce virulence factors in Candida and to kill yeast and fungus in 
laboratory tests (Cleff et al., 2010).  Essential oils have also been shown to increase the 
effectiveness of antibiotics when used in conjunction in-vivo (Langeveld, Veldhuizen, & 
Burt, 2013; Yap, Lim, Hu, & Yiap, 2013).  These published research results would 
indicate that the test methods for this study were appropriate to measure whether essential 
oil are effective when used in addition to treatment protocols in laboratory testing of 
Candida albicans isolates. 
To verify whether Candida grew or not after the treatment protocols in the 
different test variables, a colony count method using a modified Serum Inhibitory Test 
was used to quantitate how many colonies of the Candida albicans grew in culture when 




treatment.  Serum Inhibitory Titers have been used since the 1950’s and provide a 
standardized method for verifying treatment with antimicrobials (Woolfrey et al., 1986).  
This method was used as a scale to evaluate the culturing techniques and the growth 
abilities of the organism after treatment exposures.  The data points were plotted and 
compared to each test parameter and by the covariates to examine whether any other 
variables such as age, gender, race, or comorbidity affected the outcomes or risk of 
infection.   
Exposure to treatments for kill times were based upon 1 hour, 4 hours, 8 hours, 12 
hours, and 24-hour incubation.  Each Candida isolate was brought to a 0.5 McFarland 
standard, or approximately 1.5 × 108 colony forming units per milliliter (cfu/ml), using a 
5ml tryptic soy broth (TSB), acquired from Hardy Diagnostics.  This was followed by the 
addition of the treatment level.  The first protocol was done using each organism 
suspension in TSB inoculated with 10 µl of lemongrass essential oil and incubated at 
35ºC for the time intervals.  At each time interval, 10 µl of the inoculated TSB was plated 
onto Hardy Diagnostics Sabouraud Dextrose (SabDex) agar.  The Sabdex plate was then 
incubated at 35ºC and examined for growth at 24 and 48 hours.  The total colony count 
on each agar plate was recorded at the 24 and 48-hour time frames.  The absence of 
Candida growth on the agar plate after 48 hours was considered organism death.  This 
protocol was replicated each time with fresh organism suspensions and 10 µl of oregano 
essential oil; then a new suspension and 10 µl thyme; a new suspension of organism and 
10 µl of an evenly combined mixture of lemongrass, oregano, and thyme (LTO) essential 




organism suspension in TSB along with a standardized 25 µg disk of fluconazole and a 
fresh organism suspension with standardized 5 µg of caspofungin.  Then fresh organism 
suspension with 10 µl of LTO plus the 25µg disk of fluconazole and lastly a fresh 
organism suspension with 10 µl of LTO plus 5 µg of caspofungin. 
Disruption of the virulence factor of germ tube production was performed by 
inoculating a germ tube production media with each yeast isolate, incubating for 1-2 
hours and then microscopically examining for germ tube production.  This test was 
performed with just the media and the isolate to confirm that the organism produces germ 
tubes and then new germ tube media and each isolate with 5 µl of the LTO.  This was 
followed by new germ tube media, the isolate, and 25 µg fluconazole disk as well as new 
germ tube media, the isolate, and 5 µg of caspofungin. 
Establishing Reliability for the Measurement and Scale 
Reliability of a test relates to whether the test can be replicated with similar 
results (Kimberlin & Winterstein, 2008).  In this study, the ability to test and re-test for 
the same outcome on an individual isolate would be feasible due to being able to 
maintain Candida isolates for an extended length of time.  Another option for reliability 
would be to repeat the same study with an additional group of isolates from a different 
facility; from a different time-frame; or from a different specimen source.  Since all the 
isolates came from bloodstream infections, replicating the specimen source and culturing 
all the samples in the same way and incubating them for the same length of time provided 
an additional level of reliability to the test.  To ensure thorough replication, the test 




causal effect of adding essential oils for treatment was verified by evaluating whether the 
isolates that received essential oils and antifungal medications were killed in less time or 
more often than when these isolates only were exposed to the antifungal medications.  
Establishing Validity 
For a measure to have content validity it should measure the variable that it was 
intended to measure (Kimberlin & Winterstein, 2008).  Content validity is used to 
examine whether the test measures all the items the test should measure in relationship to 
the construct (Gabrenya Jr., 2003).  The measurement of Candida growth in culture was 
verified using the Clinical Laboratory Standards Institute’s (CLSI’s) guidelines (2015) 
for standardized culturing of Candida species.  The specimens collected for this study 
were all from a blood culture source.  The face validity should be high for this study 
because the measurements for culture growth have been previously established as a test 
for kill rates and minimum inhibitory concentrations (CLSI, n.d.).  The measurements 
were used to assess the construct that antifungal medications can be used to treat Candida 
infections and to assess whether the essential oils treatments provided the same or 
improved benefit (CDC: MASTER, n.d.).  The content validity for sampling is used to 
estimate how much the measure represents the actual elements in the construct (Gabrenya 
Jr., 2003).  The variables in this study were measured individually and well-established 
culture and sampling techniques were used to test for kill rates therefore, the sampling 
content validity was assumed to be strong. 
The statistical evidence that a diagnostic instrument measures what it is supposed 




of growth on culture media for Candida albicans would indicate that the treatment 
method is inhibiting the organism and not actually killing the organism.  To ensure the 
validity of culture method, the specimens were plated on agar plates that enhance yeast 
growth and then incubated for 48 hours.  The 10µl of treated broths were also inoculated 
into a new TSB tube to help facilitate inhibited organisms or low quantities of organisms 
into growing.  This enrichment broth served as a vehicle to promote growth for 
organisms that may be weakened due to a treatment that is merely fungistatic and not 
fungicidal.  These broth cultures were held for seven days to encourage the growth of 
weakened but still living yeast.  After the seven days, 10 µl of the broths were inoculated 
onto SabDex agar then incubated for 48 hours and any colony growth was recorded. 
Construct validity relates to the overarching quality of the research, the ability for 
the model to fit the data, and the ability to correlate results using the instrument 
(Alumran, Hou, Sun, Yousef, & Hurst, 2014).  The observed results of how things work 
correlate with the theoretical pattern of how things work (Kimberlin & Winterstein, 
2008).  Antifungal medications work against yeast and fungus in similar ways that 
antibiotics work against bacteria (CDC, n.d.1).  These medicines work in various ways 
including inhibiting replication of the organism or damaging the cell wall of the organism 
so that the immune system can work more effectively against the organism (CDC: 
MASTER, n.d.).  However, immunocompromised patients lack the ability of the immune 
system to interact with antimicrobials effectively due to the compromised state of the 
immune system (Pellegrino et al., n.d.).  To generalize this concept, it could be assumed 




yeast infection, then it would work as well in people that have an intact immune system.  
Utilizing a standardized test method for the growth of the organism in conjunction with 
comparing both types of treatment as well as the combined treatment also increased the 
construct validity of this research. 
The strengths for measuring growth of Candida albicans from patients with 
known infections are increased by using standardized methods for culture techniques that 
are used in microbiology laboratories around the world (CLSI, n.d.).  These methods 
have been well documented and confirmed as the best methods that are available.  The 
measurement of growth or no growth of Candida has been shown to be a valid and 
representative method for detecting Candida resistance to treatment regimens (CLSI, 
n.d.). 
Addressing Potential Weaknesses and Threats to Validity 
Potential weaknesses could be a misidentification of an organism that was 
previously identified as Candida albicans but was actually the phenotypically similar 
Candida dublinensis.  To reduce the risk of reporting results on the wrong organism, the 
isolate identifications were confirmed with a matrix assisted laser desorption/ionization- 
time of flight (Maldi-TOF).  Accurately measuring incubation time and growth results for 
each culture were tracked using a spread sheet to keep track of the time set up and time 
for each read.  Threats to external validity were minimized due to the ability to accurately 
measure culture growth for the organisms.  Rigor can be assured for validity of the study 
due to standardized culture testing using the same collection devices, the same media, 





The study to determine the effectiveness of essential oil against Candida albicans 
infections is considered an experimental test due to the attempt to correlate the cause and 
effect relationship of adding essential oils to the standard treatment and whether this 
improves the curing of Candida infections.  The testing of each isolate against both the 
antifungal treatments and the essential oil treatments to determine whether the Candida 
has survived treatment during the study is a norm-referenced test (NRT) because each 
culture was compared to the others in each individual test group as well as across the 
control and test groups ("Criterion and Standards Referenced Tests," 2007).  This type of 
comparison also allowed for the results to be compared by groups based on age, gender, 
race, and comorbidities.  The statistical software SPSS was used to perform statistical 
analyses. 
The initial research hypothesis examined lemongrass essential oil compared to the 
antifungal medications, caspofungin and fluconazole on Candida albicans kill rates.  The 
second research hypothesis examined oregano essential oil compared to caspofungin and 
fluconazole on Candida albicans kill rates.  The third research hypothesis examined 
thyme essential oil compared to caspofungin and fluconazole on Candida albicans kill 
rates.  It was hypothesized that the use of the essential oils would have a significant 
difference in kill rates compared to the standard antifungal medications.  The fourth 
hypothesis was used to evaluate the combined lemongrass, oregano, and thyme essential 
oils compared to standard antifungal medications.  It was hypothesized that the combined 




caspofungin and fluconazole.  A two-way repeated measures ANOVA was used to 
evaluate what impact the individual oils had on the organism in culture when compared 
to only exposing the culture to antifungal medications.  This was used to assess what 
impact each oil had on the treatment, what impact the combined use of the oils had on the 
treatment efficacy, how the main effects interacted, and what effect these interactions had 
on the Candida infection.  The fifth hypothesis was used to investigate the combined use 
of lemongrass, oregano, and thyme essential oils in conjunction with caspofungin and 
fluconazole.  It was hypothesized that there would be a significant difference in kill rates 
compared to the use of antifungal alone.  Again, a two-way repeated measures ANOVA 
was used to compare the groups.  The sixth research hypothesis was used to test how the 
combined use of lemongrass, oregano, and thyme essential oils compared to caspofungin 
and fluconazole to inhibit germ tube production.  It was hypothesized that there would be 
a significant difference between the combined essential oils and the antifungal 
medications on germ tube production.  This comparison was evaluated using a paired 
samples t-test.  The final research hypothesis was used to assess the covariates of age, 
gender, race, and comorbidities as risk factors for Candida albicans bloodstream 
infections.  A univariate analysis was used to determine the frequency of how many 
people in the study population belong to which age group then a binomial logistic 
regression and multinomial logistic regression were used to study the relationship 







The hospital where the isolates were collected provided a template for informed 
consent that was submitted to the hospital’s IRB prior to research approval.  This 
template as well as the IRB assured that the patients’ identities would be protected, the 
patients would not be discriminated against, and that the patients or their families would 
not be contacted in relation to this study (University of Colorado Health [UCH], n.d.).  
The data collected was entered into a UCH IRB approved computerized spreadsheet with 
the de-identified information stored on a password protected computer that is only 
accessible by myself and maintained in a secure area with limited access.  The data has 
been maintained for the duration of the research and no patient identifiers were associated 
with the data.  To reduce potential bias from the investigator on the efficacy of treatment, 
the specimens were blinded using a coded sheet and the de-identified patient 
demographics were not available while performing the experimental portion of the study.   
Summary 
Using a rigorous experimental study will enable healthcare providers to evaluate 
the research and determine whether this treatment addition is effective enough to be used 
for further research using volunteers as well as put into future recommendations as an 
improvement in best practices.  This research was developed using an experimental 
design and evaluating the risk for Candida albicans bloodstream infections based on 
gender, race, age group, and co-morbidities.  The effectiveness of treatment options was 




reducing expenses related to long-term treatment of critically ill patients with Candida 
infections.   
This chapter outlined the selection of an experimental study design and the 
rationale to investigate risks associated with gender, race, age, and co-morbidities.  The 
study variables, data access, and data collection were also addressed.  Results from this 





Chapter 4: Results  
Introduction 
The purpose of this study was to evaluate the effect of lemongrass, oregano, and 
thyme essential oils on Candida albicans’ ability to grow in the presence of each 
individual oil and the three oils combined in comparison to the antifungal treatments of 
fluconazole and caspofungin.  In addition, Candida albicans’ ability to produce germ 
tube virulence factors when exposed to the combined essential oils, caspofungin, and 
fluconazole was compared to the ability to produce germ tubes without any treatment.  
The gender, race, age group, and comorbidities of patients with Candida albicans 
bloodstream infections were also examined for potential risk factors in comparison to a 
control group that had blood cultures drawn during the same time-period but were 
negative for Candida albicans bloodstream infections.  An experimental method was 
used to create and evaluate data for the first six research questions.  A retrospective 
quantitative method was used to analyze secondary data collected from medical records 
of patients who had been hospitalized between January 2009 through August 1, 2017.  
Statistical analyses were performed to address the research questions on study variables 
and coding that were created during this study.   
In this chapter, I describe the results from the following analyses: two-way 
repeated measures ANOVA to measure the dependent variable of Candida albicans kill 
rates over time when exposed to each study variable in the first five research questions; 
descriptive statistics for virulence factors and patient demographics; binomial logistic 




regression for potential confounders, such as age, gender, race, and comorbidities 
including kidney failure, organ tumor cancer, and multiple organ failures. 
Chapter 4 is organized into four sections.  In the first section, I describe the data 
collection, discrepancies from the initial plan in Chapter 3, the demographic and 
descriptive analyses of the data collected, external validity, and the results of the 
univariate analysis to justify the inclusion of the covariates in the evaluation of patient 
demographics.  In the next section, I show the treatment methods, problems encountered, 
and how these problems were addressed.  In the third section, I reported the analyses of 
the statistical testing that was performed, assumptions that were addressed, as well as the 
additional analysis used to address the examination of multiple comorbidities.  I then 
summarize the information presented in this chapter and leads into the transition to 
discuss the results from the analyses in Chapter 5. 
Data Collection 
Descriptive statistical analyses were used to draw conclusions from the samples 
tested.  SPSS Version 24 was used to code and examine frequencies of data, relationships 
between variables, and odds ratios for potential risk factors.  Two-way repeated measures 
ANOVA, descriptive statistics, and binomial and multiple logistic regressions were used 
to evaluate the seven research questions and related hypotheses. 
1. RQ1: How does the use of lemongrass essential oil compare to standard 




H01: There is no significant difference in kill rates for the use of 
lemongrass essential oil compared to standard antifungal medications for Candida 
albicans in laboratory testing. 
Ha1: There is a significant difference in kill rates for the use of lemongrass 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
• Dependent variable: Candida albicans kill rates 
• Independent variable: treatment at set time intervals (lemongrass 
exposure at 1,4,8,12, and 24 hours; caspofungin exposure at 1,4,8,12, and 24 
hours; and fluconazole exposure at 1,4,8,12, and 24 hours). 
2. RQ2: How does the use of oregano essential oil compare to standard antifungal 
medications for Candida albicans kill rates in laboratory testing? 
H02: There is no significant difference in kill rates for the use of oregano 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Ha2: There is a significant difference in kill rates for the use of oregano 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
• Dependent variable: Candida albicans kill rates 
• Independent variable: treatment at set time intervals (oregano 
exposure at 1,4,8,12, and 24 hours; caspofungin exposure at 1,4,8,12, and 24 




3. RQ3: How does the use of thyme essential oil compare to standard antifungal 
medications for Candida albicans kill rates in laboratory testing? 
H03: There is no significant difference in kill rates for the use of thyme 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Ha3: There is a significant difference in kill rates for the use of thyme 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
• Dependent variable: Candida albicans kill rates 
• Independent variable: treatment at set time intervals (thyme 
exposure at 1,4,8,12, and 24 hours; caspofungin exposure at 1,4,8,12, and 24 
hours; and fluconazole exposure at 1,4,8,12, and 24 hours). 
4. RQ4: How does the combined use of lemongrass, oregano, and thyme essential 
oils compare to standard antifungal medications for Candida albicans kill rates in 
laboratory testing? 
H04: There is no significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils compared to standard antifungal 
medications for Candida albicans in laboratory testing. 
Ha4: There is a significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils compared to standard antifungal 
medications for Candida albicans in laboratory testing. 




• Independent variable: treatment at set time intervals (combined 
lemongrass, oregano, and thyme exposure at 1,4,8,12, and 24 hours; caspofungin 
exposure at 1,4,8,12, and 24 hours; and fluconazole exposure at 1,4,8,12, and 24 
hours). 
5. RQ5: How does the combined use of lemongrass, oregano, and thyme essential 
oils when used with standard antifungal treatments compare to standard antifungal 
medications for Candida albicans kill rates in laboratory testing?  
H05: There is no significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils when used with standard antifungal 
medications compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Ha5: There is a significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils when used with standard antifungal 
medications compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
• Dependent variable: Candida albicans kill rates 
• Independent variable: treatment at set time intervals (combined 
lemongrass, oregano, and thyme with caspofungin exposure at 1,4,8,12, and 24 
hours, and combined lemongrass, oregano, and thyme with fluconazole exposure 




6. RQ6: How does the combined use of lemongrass, oregano, and thyme essential 
oils compare to standard antifungal medications for disruption of the virulence 
factor of germ tube production of Candida albicans in laboratory testing? 
H06: There is no significant difference in the combined use of lemongrass, 
oregano, and thyme essential oils compared to standard antifungal medications for 
disruption of the virulence factor of germ tube production of Candida albicans in 
laboratory testing. 
Ha6: There is a significant difference in the combined use of lemongrass, 
oregano, and thyme essential oils compared to standard antifungal medications for 
disruption of the virulence factor of germ tube production of Candida albicans in 
laboratory testing. 
• Dependent variable: germ tube production 
• Independent variable: non-exposure; exposure to lemongrass, 
oregano, and thyme; exposure to caspofungin; and exposure to fluconazole. 
7. RQ7: How do the covariates age, gender, race, or comorbidities contribute to the 
risk of Candida albicans bloodstream infections? 
H07: Age, gender, race, or comorbidities do not significantly contribute to 
an increased risk of Candida albicans bloodstream infections. 
Ha7: Age, gender, race, or comorbidities do significantly contribute to an 
increased risk of Candida albicans blood stream infections. 
• Dependent variable: Candida albicans bloodstream infections 




Prior to analyzing the research questions, accuracy of coding the data in SPSS 
was verified, and I confirmed that appropriate statistical assumptions were met.  
Normality was determined and met for the variables in the first six research questions 
using a Q-Q plot of studentized residual for time-treatment combinations.  Mauchly’s test 
for sphericity indicated that the assumption for sphericity had been violated for the two-
way interaction between time and treatment so a correction for bias was made using a 
Greenhouse-Geisser correction.  Summary details of the variables and tests used to 
evaluate the hypotheses are displayed in Table 1. 
Table 1 Summary Details of Variables and Analyses used to Evaluate Hypotheses 
Note. CABSI: Candida albicans bloodstream infections 
LTO: Lemongrass, thyme, oregano essential oils combined 
Descriptive Statistics 
The initial criteria for selecting study participants were patients hospitalized 
between January 2009 and August 1, 2017, in the age range of 18 through 74, who 
acquired Candida albicans bloodstream infections during their length of stay at the 
hospital.  Once the number of patients during that time frame were gathered, the same 
number of patients during the time period with blood cultures collected during a hospital 
stay but negative for Candida albicans bloodstream infections were also collected.  From 
Hypotheses  Independent Variable Dependent Variable  Analysis 





6 Germ tube production LTO vs Caspofungin vs Fluconazole 
Chi-square Test of 
Independence 
 






the 120 positive samples, the total number of Candida albicans isolates that were able to 
be recovered from the frozen archives were 117.  Although this was one less than the 
G*Power analysis requirements of 118 for an effect size 0.25, using 117 still fit the 
analysis for a power (1-β) =1.0 and an α err of 0.05.  For the patients with Candida 
albicans bloodstream infections during the collection time, a total of 107 patients were in 
the age range of 18-74.  Analysis of 113 randomized hospitalized patients with blood 
cultures during the same period who did not have Candida albicans infections and were 
in the selected age range was also performed.  Using a G*Power analysis for logistic 
regression with the total sample size for the patient demographics of 220, the power (1-β 
err prob) = 0.992.  Due to time and space constraints, the experiments to investigate the 
first six research questions were divided into five groups.  Initial tests were performed on 
20 isolates with seven of the test levels (lemongrass, thyme, oregano, combined oils, 
fluconazole, and combined oils with fluconazole).  On this first day, time to kill rates 
were collected at 1, 4, 8, 12 hours, and the following day at 24 hours.  These inoculated 
plates were incubated at 35°C, and colony counts were recorded at 24 hours and then 
again at 48 hours to more accurately ensure organism death versus inhibition.  On the 
second day, an additional 20 isolates were tested with these initial incubation times 
overlapping with the first set of isolates incubation period.  With this many culture plates, 
after the initial 24 hours of incubation and examination for colony growth, the 24-48-hour 
culture plate incubation was performed at 25°C instead of 35°C.  This lower incubation 
does not impact the colony growth, only the size of the colonies.  All colony counts were 




Incubation of all the isolates in TSB were performed at 35°C for the duration of the 
experiment.  Additional isolate groups were performed on subsequent weekends when 
adequate space and time were available.  Due to delivery difficulties of the antifungal, 
caspofungin, all 117 isolates were tested against caspofungin and caspofungin with the 
combined essential oils on the same weekend.   
The test for the virulence factor of germ tube production was conducted during 
these same time-frames.  For the 117 isolates, 108 (92.3%) produced germ tubes in the 
germ tube test medium alone; when the combined essential oils of lemongrass, thyme, 
and oregano were added to germ tube test medium, 116 isolates did not produce germ 
tubes and the germ tubes of the remaining isolate were abnormally large and deformed.  
Adding caspofungin to the germ tube medium produced germ tubes in 110 of the isolates 
(94.0%).  The addition of fluconazole to the germ tube medium also resulted in 110 of the 
isolates producing germ tubes.  Adding caspofungin or fluconazole promoted germ tube 
production in two additional isolates that did not produce germ tubes in the initial germ 
tube medium only.  These additional germ tube producing isolates were not the same 
isolates for both fluconazole and caspofungin but rather four separate isolates.  Seven 
days following each set of experimental testing, each TSB broth was also sub-cultured 
again to SabDex and examined for growth after 48 hours incubation at 35°C.  None of the 
isolates that had been exposed to any essential oil treatment in the TSB broth, including 
those combined with the antifungals, were able to grow after 48 hours on the SabDex 
medium.  All the isolates that had been exposed to only caspofungin or fluconazole were 




collection was completed for the experimental portion of the study, patient demographics 
were collected.  
While collecting patient demographics, any comorbidity listed upon admission 
was documented.  After all the demographics were collected for the test and control 
groups, a binomial logistic regression was performed to investigate the effects of age, 
race, gender, and comorbidities on the likelihood of acquiring Candida albicans 
bloodstream infections after admission.  There were 15 individual comorbidities with 
multiple patients having more than one comorbidity.  The initial individual comorbidities 
examined were diabetes, HIV/AIDS, kidney/renal failure, solid organ tumor cancer, 
haemotologic malignancy, substance abuse, abdominal surgery, severe burns, organ 
transplant, stem cell transplant, other surgeries, soft tissue cancer, autoimmune disorder, 
multiple organ failure, and the rest were combined into an “other” category (see Table 2).   
Table 2 Patient Data Collection 
  CABSI – Yes CABSI – No 
Number of cases (n)  107 113 
Age Group 18-24 5 (4.7) 5 (4.4) 
 25-34 24 (22.4) 7 (6.2) 
 35-44 16 (14.9) 19 (16.8) 
 45-54 19 (17.8) 22 (19.5) 
 55-59 11 (10.3) 19 (16.8) 
 60-64 12 (11.2) 11 (9.7) 
 65-74 20 (18.7) 30 (26.6) 




Table 2 continued  CABSI-Yes CABSI-No 
 Female 49 (45.8) 44 (38.9) 
Race White 69 (64.5) 62 (54.9) 
 Black 10 (9.3) 23 (20.4) 
 Hispanic 16 (15.0) 17 (15.0) 
 Other/Unknown 12 (11.2) 11 (9.7) 
Comorbidities Diabetes 21 (19.6) 23 (20.4) 
 Kidney Failure 41 (38.3) 25 (22.1) 
 Solid Tumor Cancer 27 (25.2) 14 (12.4) 
 Haemotologic 
Malig, 
1 (0.9) 3 (2.6) 
 Substance Abuse 8 (7.5) 8 (7.1) 
 Abdominal Surgery 11 (10.3) 5 (4.4) 
 Burns 4 (3.7) 2 (1.8) 
 Organ Transplant 14 (13.1) 13 (11.5) 
 HIV/AIDS 1 (0.9) 3 (2.6) 
 Stem Cell Transplant 0 (0) 2 (1.8) 
 Other Surgery 6 (5.6) 6 (5.3) 
 Soft Tissue Cancer 4 (3.7) 0 (0) 
 Autoimmune 
Disorder 
5 (4.7) 0 (0) 
 Multi Organ Failure 9 (8.4) 25 (22.1) 
Note: CABSI: Candida albicans bloodstream infection 
While this model correctly classified 75% of the cases and explained 43% 
(Nagelkerke R2) of the variance in Candida albicans bloodstream infections, the effect of 




comorbidities were then reclassified individually and a multinomial regression was 
performed to assess potential confounders. 
There were 49 females out of 107 patients in the test group (45.8%) with a 
slightly lower amount of 44 females in the control group of 113 (38.9%).  The most 
CABSI were in the age group 25-34 and the highest number for the control subjects was 
in the 65-74 age group (see Figure 3). 
Figure 3.  Percent of CABSI and non-CABSI by age group. 
Race was categorized based upon hospital demographics of White, Black, 
Hispanic, or other/unknown.  The other category includes records where race/ethnicity 
were entered as unknown and for other groups which were in small numbers where de-
identification would be difficult.  Most of the patients in the test and control groups seen 
at the hospital during this collection period were listed as White. Positive for CABSI 
group had 64.5% listed as White and the control group (non-CABSI) had 54.9% listed as 
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Figure 4. Percent of CABSI and non-CABSI by race. 
Categorizing comorbidities as individual variables and calculating a Chi-square 
test for association for each comorbidity with CABSI showed that kidney failure, solid 
organ tumor cancer, autoimmune disorder, and multiple organ failure all had a 
statistically significant association with CABSI however, for the autoimmune disorder, 
not all expected cell frequencies were greater than 5 and therefore not included in the 
final analyses.  A multiple logistic regression was then performed on the combined 
control and test groups for the comorbidities of kidney failure, solid organ tumor cancer, 
and multiple organ failure.  Combining the control group with the test group to the 
analysis provided additional data points to determine whether any of these factors could 
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Analyses of Tests for Hypotheses 
Hypotheses 1-5 were evaluated using two-way repeated measures ANOVA to 
determine if any statistically significant differences existed between treatment types over 
a 24-hour time-frame.  Hypothesis 6 was evaluated using a Chi-square test for 
independence and to examine hypothesis 7, a binomial logistic regression was utilized 
followed by a multinomial logistic regression to investigate potential confounders.  
Specifically, the dependent variable for hypotheses 1-5 was the kill rates for Candida 
albicans when exposed to the independent variables of treatment. Hypothesis 6 had a 
dependent variable of germ tube production and hypothesis 7 had a dependent variable of 
Candida albicans bloodstream infection.   
The independent variables for hypotheses 1-5 were treatment with lemongrass, 
oregano, thyme, combined essential oils, caspofungin, fluconazole, caspofungin with the 
combined essential oils, and fluconazole with the combined essential oils.  The 
independent variables for hypothesis 6 were no treatment, treatments with combined 
essential oils, fluconazole, or caspofungin.  The independent variables for hypothesis 7 
included age, race, gender, and comorbidities.  Initial comorbidities included 12 variables 
with only three with statistically significant results. 
Results of Hypothesis 1 
H01: There is no significant difference in kill rates for the use of lemongrass 





Ha1: There is a significant difference in kill rates for the use of lemongrass 
essential oil compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Using SPSS 24, a two-way repeated measures ANOVA was conducted to 
determine whether statistically significant differences existed between treatment with 
lemongrass, caspofungin, and fluconazole over five time-measurements. Results of mean 
colony counts after a 24-hour plate incubation, indicated that at each exposure interval, 
there was a lower mean colony count for lemongrass compared to exposure to 
caspofungin and fluconazole.  After an 8-hour exposure to lemongrass, the colony count 
mean dropped to 0, the caspofungin colony count continued to lower, but after an 8-hour 
exposure to fluconazole, the mean colony count increased above the 4- hour exposure.  
Twelve- hour exposure to lemongrass again resulted with a mean of 0 colonies, colony 
counts for caspofungin rose slightly, and fluconazole mean colony counts decreased 
again.  At the end of 24-hour exposure times, colony counts for exposure to lemongrass 
remained at 0, caspofungin rose slightly, and colony counts for exposure to fluconazole 




Figure 5. Mean colony count of lemongrass, caspofungin, and fluconazole at 
24hr. 
 
The agar plates for these colony counts were then re-incubated for another 24 
hours.  Results of mean colony counts after the 48-hour plate incubation, indicated that at 
each exposure interval, there was a lower mean colony count for lemongrass compared to 
exposure to caspofungin and fluconazole.  For the 8-hour exposure to lemongrass, the 
colony count mean stayed at zero.  The caspofungin colony count was also lower, but the 
8-hour exposure to fluconazole, agar plate at 48 hours incubations was above the 4-hour 
exposure count similar to the results after 24 hours incubation.  Twelve- hour exposure to 
lemongrass again resulted with a mean of 0 colonies, colony counts for caspofungin rose 
slightly, and fluconazole mean colony counts decreased again.  At the end of 24-hour 
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rose slightly, and colony counts for exposure to fluconazole increased substantially (see 
Figure 6). 
Figure 6. Mean colony count of lemongrass, caspofungin, and fluconazole at 48hr. 
Mean colony count results for 1-hour, 4-hour, 8-hour, 12-hour, and 24-hour 
exposure to lemongrass, caspofungin, and fluconazole at 24-hour plate incubation and 
48-hour plate incubation are listed in Table 3.   




Lemongrass Caspofungin Fluconazole 












1 hour 18.17 28.48 36.66 38.31 50.59 53.97 
4 hour 5.22 8.54 19.13 21.56 50.95 53.47 
8 hour 0 0 9.21 11.25 58.77 62.65 
12 hour 0 0 9.71 11.35 51.58 55.73 
24 hour 0 0 11.60 12.19 85.26 86.73 
 
Results for lemongrass exposure after the increased plate incubation time showed 
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increase in mean colony counts could indicate that at these lower exposure times the 
organisms are being inhibited and are not completely killed.  However, the 8-hour, 12-
hour, and 24-hour exposures to lemongrass maintained 0 mean colony counts which 
would indicate that after sufficient exposure to lemongrass, the organisms are no longer 
viable.   
Caspofungin also had higher colony counts after 48-hours plate incubation, 
verifying the antifungal inhibition properties.  The mean colony counts for caspofungin at 
24-hours and 48-hours plate incubation followed the same pattern of decreasing colony 
count at 4-hours and 8-hours but beginning to increase again after 12 hours of exposure.  
Caspofungin is considered to be fungicidal however, the organisms were not killed in the 
time-frame of these experiments.  Without additional antifungal being added, the 
organisms were able to overcome the inhibition action of caspofungin and continue to 
proliferate. 
Fluconazole had higher mean colony counts at the 24-hour and 48-hour plate 
incubations.  Interestingly, the mean colony counts for Candida albicans with 
fluconazole exposure decreased at the 4-hour and 12-hour exposure but not at the 8-hour 
exposure and then had a substantial increase after 24 hours of exposure.  The increase in 
the mean colony counts at 8-hours of exposure were duplicated at the 24-hour and 48-
hour plate incubations.  Clearly fluconazole is shown to begin to inhibit the organisms, 
however this spike at 8 hours and jump at 24 hours may indicate that the medication may 
not be able to sustain inhibition after 4 hours and drug dosing could become very 




than both caspofungin or fluconazole for all exposure times at the 24-hour and 48-hour 
plate incubations. 
The mean kill rates of lemongrass essential oil were statistically significant over 
time, F(1.617, 187.191)= 40.865, p<.0005.  Test of within subject effect using a 
Greenhouse-Geisser correction for the time and treatment interaction effect is .000 
(p<.0005).  There was a statistically significant interaction between lemongrass treatment 
and time (see Table 4).   
Table 4 Tests of With-In Subjects of Lemongrass Treatment Over Time 
Source  df F Sig. 
Lemongrass 1.617 40.865 <.001 
Error (Lemongrass) 187.191   
 
Over the time that Candida albicans isolates were exposed to lemongrass the 
ability for the organisms to survive and proliferate decreased until at 8-hours of exposure, 
the organisms were no longer viable.  Using a pairwise comparison to measure 
lemongrass exposure to caspofungin exposure, there was a colony count mean difference 
of -12.582, 95% CI [-17.429 to -7.735], p<.0001 for lemongrass exposure compared to 
caspofungin exposure.  For the pairwise comparison of lemongrass exposure to 
fluconazole exposure, the mean colony count difference was -54.50, 95% CI [-62.108 to -







Table 5 Pairwise Comparison Between Treatments 
(I) to (J) treatment Mean Difference (I-J) Std. Error Sig. 95% CI  
Lemongrass to Caspofungin -12.582 1.514 <.001 -17.429, -
7.735 
Lemongrass to Fluconazole -54.750 2.299 <.001 -62.108, -
47.392 
 
Lemongrass exposure had a statistically significant lower mean colony count after 
exposure when compared to caspofungin and fluconazole.  Therefore, the null hypothesis 
can be rejected in favor of the alternate hypothesis. 
Results of Hypothesis 2 
H02: There is no significant difference in kill rates for the use of oregano essential 
oil compared to standard antifungal medications for Candida albicans in laboratory 
testing. 
Ha2: There is a significant difference in kill rates for the use of oregano essential 
oil compared to standard antifungal medications for Candida albicans in laboratory 
testing. 
A two-way repeated measures ANOVA was conducted to determine whether 
statistically significant differences existed between treatment with oregano, caspofungin, 
and fluconazole over five time-measurements.  Results indicated that at each time 
exposure to oregano, there was a mean colony count of 0.  Exposure to caspofungin and 
fluconazole were discussed under Hypothesis 1 results.  Results of mean colony counts 




obvious lower mean colony count for oregano compared to exposure to caspofungin and 
fluconazole (see Figure 7). 
 Figure 7. Mean colony count of oregano, caspofungin, and fluconazole at 24hr. 
The agar plates for these colony counts were then re-incubated for another 24 
hours.  The 48-hour growth for colony counts after 1-hour exposure to oregano increased 
slightly to .05.  All other time exposures with oregano had a mean colony count of 0 
which was consistent with the 24-hour plate incubation.  Caspofungin and fluconazole 
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Figure 8. Mean colony count of oregano, caspofungin, and fluconazole at 48hr. 
As indicated in Table 6, overall, oregano had a lower mean colony count than 
both caspofungin or fluconazole for all exposure times at the 24-hour and 48-hour plate 
incubations.   




           Oregano          Caspofungin            Fluconazole 












1 hour 0 0 36.66 38.31 50.59 53.97 
4 hour 0 0 19.13 21.56 50.95 53.47 
8 hour 0 0 9.21 11.25 58.77 62.65 
12 hour 0 0 9.71 11.35 51.58 55.73 
24 hour 0 0 11.60 12.19 85.26 86.73 
 
The mean kill rates of oregano essential oil were not statistically significant over 
time, F(1, 116)= 1.813, p=.181.  This is due to the lack of colony growth throughout the 
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significant, the fact that oregano killed off the Candida albicans isolates in such a short 
exposure time provides an area to determine with future research whether this in-vitro 
phenomenon would replicate in-vivo. 
Using a pairwise comparison to measure oregano exposure to caspofungin 
exposure, there was a colony count mean difference of –17.261, 95% CI [-21.499 to -
13.023], p<.0001 for oregano exposure compared to caspofungin exposure. For the 
pairwise comparison of oregano exposure to fluconazole exposure, the mean colony 
count difference was -59.429, 95% CI [-67.025 to-51.832], p<.0001 (see table 7).   
 
Table 7 Pairwise Comparison Between Treatments 
(I) to (J) treatment Mean Difference (I-J) Std. Error Sig. 95% CI  
Oregano to Caspofungin -17.261 1.324 <.001 -21.499, -13.023 
Oregano to Fluconazole -59.429 2.373 <.001 -67.025, -51.832 
 
Oregano exposure had a statistically significant lower mean colony count after 
exposure when compared to caspofungin and fluconazole.  Therefore, the null hypothesis 
can be rejected in favor of the alternate hypothesis. 
Results of Hypothesis 3 
H03: There is no significant difference in kill rates for the use of thyme essential 
oil compared to standard antifungal medications for Candida albicans in laboratory 
testing. 
Ha3: There is a significant difference in kill rates for the use of thyme essential oil 




A two-way repeated measures ANOVA was conducted to determine whether 
statistically significant differences existed between treatment with thyme, caspofungin, 
and fluconazole over five time-measurements.  Mean colony count results for 1-hour, 4-
hour, 8-hour, 12-hour, and 24-hour exposure to thyme, caspofungin, and fluconazole at 
24-hour plate incubation and 48-hour plate incubation are listed in Table 8.  Results 
indicated that at 8, 12 and 24-hour time exposure to thyme, there was a mean colony 
count of 0.  Exposure to caspofungin and fluconazole were discussed under Hypothesis 1 
results.  Results of mean colony counts after a 24-hour plate incubation, indicated that at 
each exposure interval, there was a lower mean colony count for thyme compared to 
exposure to caspofungin and fluconazole (see Figure 9).   
Figure 9. Mean colony count of thyme, caspofungin, and fluconazole at 24hr. 
The agar plates for these colony counts were then re-incubated for another 24 
hours.  Results for thyme exposure after the increased plate incubation time showed a 
slight increase in mean colony counts for the 1-hour and 4-hour exposure times.  This 
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organisms are being inhibited and are not completely killed.  However, the 8-hour, 12-
hour, and 24-hour exposures to thyme maintained 0 mean colony counts which would 
indicate that after sufficient exposure to thyme, the organisms are no longer viable. (see 
Figure 10). 
Figure 10. Mean colony count of thyme, caspofungin, and fluconazole at 48hr. 
Overall, thyme also had a lower mean colony count than both caspofungin or 
fluconazole for all exposure times at the 24-hour and 48-hour plate incubations.  
Caspofungin and fluconazole mean colony counts were previously discussed under 
Hypothesis 1 results.  Thyme mean colony counts were below 1 colony forming unit after 
the 48-hour plate incubation at the 4-hour exposure, this would indicate that similar to 
oregano, further testing into in-vivo reactions could provide additional avenues for 
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Thyme Caspofungin Fluconazole 












1 hour 3.73 5.75 36.66 38.31 50.59 53.97 
4 hour 0 0.40 19.13 21.56 50.95 53.47 
8 hour 0 0 9.21 11.25 58.77 62.65 
12 hour 0 0 9.71 11.35 51.58 55.73 
24 hour 0 0 11.60 12.19 85.26 86.73 
 
The mean kill rates of thyme essential oil were statistically significant over time, 
F(1.108, 128.571)= 18.339, p<.0001.  Test of within subject effect using a Greenhouse-
Geisser correction for the time and treatment interaction effect is .000 (p<.0005).  There 
was a statistically significant interaction between thyme treatment and time (see Table 9).   
Table 9 Tests of With-In Subjects of Thyme Treatment Over time 
Source df F Sig. 
Thyme 1.108 18.339 <.001 
Error (Thyme) 128.571   
 
Over the time that Candida albicans isolates were exposed to thyme the ability 
for the organisms to survive and proliferate decreased until the organisms were no longer 
viable.  Using a pairwise comparison to measure thyme exposure to caspofungin 
exposure, there was a colony count mean difference of –16.482, 95% CI [-20.631 to -
12.333], p<.0001 for thyme exposure compared to caspofungin exposure.  For the 
pairwise comparison of thyme exposure to fluconazole exposure, the mean colony count 





Table 10 Pairwise Comparison Between Treatments 
(I) to (J) treatment Mean Difference (I-J) Std. Error Sig. 95% CI  
Thyme to Caspofungin -16.482 1.296 <.001 -20.631, -12.333 
Thyme to Fluconazole -58.650 2.386 <.001 -66.286, -51.014 
 
Thyme had a statistically significant lower mean colony count after exposure 
when compared to caspofungin and fluconazole.  Therefore, the null hypothesis can be 
rejected in favor of the alternate hypothesis. 
Results of Hypothesis 4 
H04: There is no significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils compared to standard antifungal 
medications for Candida albicans in laboratory testing. 
Ha4: There is a significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils compared to standard antifungal 
medications for Candida albicans in laboratory testing. 
A two-way repeated measures ANOVA was conducted to determine whether 
statistically significant differences existed between treatment of the combined use of 
lemongrass, oregano, and thyme (LTO), with caspofungin, and fluconazole over five 
time-measurements.  Results indicated that at 1-hour, 4-hour, and 8-hour exposure to 
LTO, there was colony growth.  However, at the 12 and 24-hour exposure the mean 
colony count for LTO was zero.  Exposure to caspofungin and fluconazole were 





Figure 11. Mean colony counts for lemongrass, oregano, and thyme (LTO), caspofungin, 
and fluconazole at 24hr. 
 
The agar plates for these colony counts were then re-incubated for another 24 
hours.  The 48-hour growth for colony counts after 1-hour, 4-hour, and 8-hour exposure 
to LTO increased slightly.  Caspofungin and fluconazole results after the 48-hour plate 
incubation were previously discussed (see Figure 12). 
Figure 12. Mean colony counts for lemongrass, oregano, and thyme (LTO), caspofungin, 
and fluconazole at 48hr.  
 
Overall, LTO had a lower mean colony count than both caspofungin or 
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Combining the three essential oils seems to have a slightly antagonistic effect on 
organism death seen with higher mean colony counts at 1-hour, 4-hour and 8-hour 
exposure.  However, at the 12-hour and 24-hour exposure times the effect appears equal 
to testing each oil individually (see Table 11).   





                LTO Caspofungin Fluconazole 












1 hour 18.63 21.71 36.66 38.31 50.59 53.97 
4 hour 1.83 3.87 19.13 21.56 50.95 53.47 
8 hour 0.74 1.57 9.21 11.25 58.77 62.65 
12 hour 0 0 9.71 11.35 51.58 55.73 
24 hour 0 0 11.60 12.19 85.26 86.73 
Note: LTO: Combined Lemongrass, Oregano, and Thyme 
The mean kill rates of LTO combined essential oils were statistically significant 
over time, F(1.609, 186.643)= 79.476, p<.0001 (see Table 12). 
Table 12 Tests of With-In Subjects of LTO Treatment Over Time 
Source df F Sig. 
LTO 1.609 79.476 <.001 
Error (LTO) 186.643   
Note: LTO: Combined Lemongrass, Oregano, and Thyme 
Using a pairwise comparison to measure LTO exposure to caspofungin exposure, 
there was a colony count mean difference of –12.995, 95% CI [-17.903 to -8.086], 




mean colony count difference was-55.163, 95% CI [-62.454 to -47.871], p<.0001 (see 
Table 13).   
Table 13 Pairwise Comparison Between Treatments 
 
(I) to (J) treatment Mean difference (I-J) Std. Error Sig. 95% CI  
LTO to Caspofungin -12.995 1.533 <.001 -17.903, -8.086 
LTO to Fluconazole -55.163 2.278 <.001 -62.454, -47.871 
 
LTO had a statistically significant lower mean colony count after exposure when 
compared to caspofungin and fluconazole.  Therefore, the null hypothesis can be rejected 
in favor of the alternate hypothesis. 
Results of Hypothesis 5 
H05: There is no significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils when used with standard antifungal 
medications compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
Ha5: There is a significant difference in kill rates for the combined use of 
lemongrass, oregano, and thyme essential oils when used with standard antifungal 
medications compared to standard antifungal medications for Candida albicans in 
laboratory testing. 
A two-way repeated measures ANOVA was conducted to determine whether 
statistically significant differences existed between treatment of the use of LTO 
combined with caspofungin and the use of LTO combined with fluconazole, compared to 




exposure to LTO plus caspofungin (LTO+C) and LTO plus fluconazole (LTO+F), mean 
colony counts were similar to each other but markedly lower than caspofungin or 
fluconazole alone.  Caspofungin and fluconazole mean colony counts were discussed 
under Hypothesis 1 results at length.  The results at 4 hours for both LTO+C exposure 
LTO+F exposure dropped to mean colony counts below 1.  After 8-hour exposure and 
12- hour exposure to LTO+C, the mean colony counts stayed close to zero but at 24-hour 
exposure, the mean colony count rose slightly to 0.51.  At 8, 12, and 24-hour exposure to 
LTO+F, mean colony counts dropped to zero (see Figure 13). 
Note: LTO+C: Lemongrass, Oregano, and Thyme combined with Caspofungin 
  LTO+F: Lemongrass, Oregano, and Thyme combined with Fluconazole 
Figure 13. Mean colony counts of LTO+C, LTO+F, caspofungin, and fluconazole at 24 
hr. 
 
The agar plates for these colony counts were then re-incubated for another 24 
hours.  The 48-hour growth for colony counts after 1-hour exposure to LTO+C increased 
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48-hour plate incubation were seen at the 4-hour and 8-hour exposure for LTO+C, while 
maintaining the same mean colony count at 12-hour exposure and raising slightly at 24-
hour exposure but still at less than 1 mean colony count.  The LTO+F after the 48-hour 
plate incubation had almost 2 colonies for the mean count but dropped to 0.5 at the 8-
hour exposure time and subsequent exposure hours of 12 and 24 maintained a 0 mean 
colony count (see Figure 14). 
Note: LTO+C: Lemongrass, Oregano, and Thyme combined with Caspofungin 
  LTO+F: Lemongrass, Oregano, and Thyme combined with Fluconazole 
Figure 14. Mean colony counts of LTO+C, LTO+F, caspofungin, and fluconazole at 
48hr. 
 
Both combinations seemed to be more effective after the 1-hour exposure than 
LTO alone or caspofungin or fluconazole alone.  However, when isolates were exposed 
to LTO combined with caspofungin there was a less than 1 mean colony count at 4-hours 
of exposure and this was maintained at subsequent exposure times.  A 0 mean colony 
count was not achieved with LTO+C like it was at 12 and 24-hour exposure with LTO 
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  LTO+C  LTO+F Caspofungin Fluconazole 
















1 hour 6.03 7.51 8.18 16.10 36.66 38.31 50.59 53.97 
4 hour .07 .10 .53 1.96 19.13 21.56 50.95 53.47 
8 hour .04 .07 0 .05 9.21 11.25 58.77 62.65 
12 hour .05 .05 0 0 9.71 11.35 51.58 55.73 
24 hour .51 .54 0 0 11.60 12.19 85.26 86.73 
Note:  P.I.: Plate Incubation.  LTO+C: Lemongrass, Oregano, Thyme and Caspofungin 
LTO+F: Lemongrass, Oregano, Thyme and Fluconazole 
 
The mean kill rates of LTO+C were statistically significant over time, F(1.068, 
123.887)= 33.079, p<.0001.  For LTO+F the mean kill rates were statistically significant 
over time, F (1.399, 160.871) = 68.639, p<.0001 (see Table 15).  Indicating that in 
laboratory testing, combining LTO with either caspofungin or fluconazole increased the 
cellular death of Candida albicans isolates over exposure time.   
Table 15 Tests of With-In Subjects of LTO+C and LTO+F Treatment Over Time 
Source Df F Sig, 
LTO + Caspofungin 1.068 33.079 <.001 
Error (LTO + Caspo) 123.887   
LTO + Fluconazole 1.399 68.639 <.001 
Error (LTO + Fluc) 160.871   
 
Using a pairwise comparison to measure LTO+C exposure to caspofungin 
exposure, there was a colony count mean difference of –15.913, 95% CI [-20.148 to -
11.677], p<.0001.  For the pairwise comparison of LTO+C exposure to fluconazole 




p<.0001.  Using the pairwise comparison for LTO+F to caspofungin exposure, there was 
a colony count mean difference of -15.502, 95% CI [-20.034 to -10.970], p<.001.  For the 
pairwise comparison of LTO+F to fluconazole exposure, there was a mean colony count 
difference of -57.670, 95% CI [ -64.812 to -50.527], p<.001 (see Table 16).   
Table 16 Pairwise Comparison Between Treatments 
(I) to (J) treatment Mean Difference (I-J) Std. Error Sig. 95% CI  
LTO+C to Caspofungin -15.913 1.323 <.001 -20.148, -11.677 
LTO+C to Fluconazole -58.080 2.369 <.001 -65.663, -50.498 
LTO+F to Caspofungin -15.502 1.416 <.001 -20.034, -10.970 
LTO+F to Fluconazole -57.670 2.231 <.001 -64.812, -50.527 
Note: LTO+C: Lemongrass, Oregano, and Thyme + Caspofungin 
LTO+F: Lemongrass, Oregano, and Thyme + Fluconazole 
LTO+C and LTO+F both had a statistically significant lower mean colony count 
after exposure when compared to caspofungin and fluconazole.  Therefore, the null 
hypothesis can be rejected in favor of the alternate hypothesis. 
Results of Hypothesis 6 
H06: There is no significant difference in the combined use of lemongrass, 
oregano, and thyme essential oils compared to standard antifungal medications for 
disruption of the virulence factor of germ tube production of Candida albicans in 
laboratory testing. 
Ha6: There is a significant difference in the combined use of lemongrass, oregano, 
and thyme essential oils compared to standard antifungal medications for disruption of 
the virulence factor of germ tube production of Candida albicans in laboratory testing. 
To evaluate whether LTO exposure resulted in a significant decrease of germ tube 




test was used.  The frequency of germ tube production with no exposures was 92.3% of 
the isolates produced germ tubes.  Indicating that 7.7% of the Candida albicans isolates 
tested were not able to produce germ tubes in when exposed to media that enhances germ 
tube production.  When exposed to LTO only one isolate produced germ tubes that were 
abnormally large and deformed this means that 99.1% of the isolates when exposed to 
LTO were unable to produce germ tubes.  When the isolates were exposed to 
caspofungin, 94.0% of the isolates were still able to produce germ tubes.  For exposure to 
fluconazole, there were also still 94.0% of the isolates able to produce germ tubes.  Germ 
tube testing with each treatment mode was performed simultaneously with the organism 
and only germ tube media as a control to ensure which organisms were able to produce 
germ tubes.  By performing the testing at the same time, ensured that the organism had 
not lost the ability to produce germ tubes if the testing had been done with different 
subcultures of isolates at different times.  Including the control group also verified that 
the organisms were still able to produce germ tubes since testing the caspofungin had to 
occur at a later date than the LTO and fluconazole testing.  The manufacturer also 
indicates that there should be no more than six cells per 400x field to prevent false 
negative results.  Each testing vial was verified to not be over inoculated (data not 
shown). 
Comparing the ability for the organisms to naturally produce germ tubes in 
specialized medium (GTM) with exposure to LTO in the specialized medium, a paired 
samples t-test was performed to determine whether there was a significant difference first 




alpha level, t(116) =30.512, p<.0001.  Comparing LTO exposure to caspofungin 
exposure for germ tube production, the paired samples t-test indicated that the t-statistic 
was significant at the 0.5 critical alpha level, t(116)= -33.495, p<.0001.  Comparison of 
LTO and fluconazole exposure was also performed using a paired samples t-test that was 
significant at the 0.5 critical alpha level, with the same results of t(116) = -33.495, 
p<.0001 (see Table 17).  Therefore, the null hypothesis can be rejected, and the alternate 
can be accepted.   
Table 17 Comparison of Germ Tube Production Using Paired Samples t-Test 
 
Paired Differences     t df Sig. (2-tailed) Mean  95% CI (Lower, Upper) 
GTM to LTO 30.512 116 .000 .906        .847, .965 
LTO to Caspo -33.495 116 .000 -.923       -.978, -.868 
LTO to Fluc -33.495 116 .000 -.923       -.978, -.868  
 
Results of Hypothesis 7 
H07:  Age, gender, race, or comorbidities do not significantly contribute to an 
increased risk of Candida albicans bloodstream infections. 
Ha7: Age, gender, race, or comorbidities do significantly contribute to an 
increased risk of Candida albicans blood stream infections. 
To determine whether age, gender, race or comorbidities could be risk factors for 
CABSI, a binomial logistic regression was performed to determine the probability of 
being in the category of CABSI given the independent variables.  Test for linearity was 
not needed as all the independent variables are nominal and not continuous (Laerd 
Statistics, 2015).  The logistic regression model was statistically significant, χ2(28) 




and correctly classified 75% of the cases.  Sensitivity was 78%, specificity was 87%, the 
positive predictive value was 75%, and the negative predictive value was also 75%.  In 
this model with all the comorbidities coded under one heading the only statistically 
significant variable was the age group 25-34.  To further investigate the factors associated 
with the comorbidities, each comorbidity was separated into individual variables.  A Chi-
square goodness of fit test was performed to determine the highest level of prediction.  
With age as a covariate, the model predicted 69.1% of the cases with a Pearson goodness 
of fit of 115.295(106), p=.253.  Using gender as a covariate, the model predicted 70% of 
the cases correctly with a Pearson goodness of fit 112.424 (101), p=2.47.   
Race as a covariate correctly predicted 69.5% of the cases with a Pearson 
goodness of fit 112.418 (103), p=2.47.  Utilizing comorbidities separately, kidney failure 
as a covariate predicted 70% of the cases with Pearson goodness of fit at 112.24(101), 
p=.206.  Solid organ tumor cancer, autoimmune disorder, or multiple organ failure as 
individual covariates all predicted the cases at the same level of 67.3% with a Pearson 
goodness of fit of 42.305(13), p<.0001.  Multiple combinations of covariates did not 
improve the predictability of correct cases (data not shown). 
Next a Chi-square test for association was done to determine which comorbidities 
were significantly associated with CABSI.  There was a statistically significant 
association between CABSI and kidney failure, χ2(1) = 6.863, p=.009.  Other statistically 
significant associations with CABSI and a comorbidity included solid organ tumor, χ2 = 
5.980 (1), p=.014, and multiple organ failure χ2 = 7.909 (1), p=.005.  Autoimmune 




greater than 5 cases for a Chi-square test for association and thus it was not included in 
further analysis.  To consider the overall effect of statistically significant nominal 
variables, a likelihood ratio test was evaluated in SPSS.  With no covariates, age, kidney 
failure, solid organ tumor cancer, and multiple organ failure were all statistically 
significant (see Table 18). 
 Table 18 Likelihood Ratio Test (No Covariates) 
 
Effect Chi-square df Sig. 
Age 8.774 1 .003 
Kidney Failure 9.584 1 .002 
Solid Organ Tumor Cancer 7.835 1 .005 
Multiple Organ Failure 7.237 1 .007 
 
Using age as a covariate the variables kidney failure, solid organ tumor cancer, 
and multiple organ failure were all still statistically significant (see Table 19).  
Table 19 Likelihood Ratio Test (Covariate of Age) 
 
Effect Chi-square df Sig. 
Kidney Failure 10.614 1 <.001 
Solid Organ Tumor Cancer 8.904 1 .003 
Multiple Organ Failure 8.068 1 .005 
Age 18.795 6 .005 
 
A binary logistic analysis was used next since the dependent variable has two 
outcomes (yes or no).  Using age as the only independent variable correctly predicted 




independent variable predicted 58.6% of the case with Exp(β) = 2.187, p=.009.  Using 
solid organ tumor cancer as the only independent variable predicted 57.3% of the cases 
with Exp(β) = 2.387, p.016.  Multiple organ as the only independent variable predicted 
55.9% of the cases correctly with Exp(β) = .323, p=.007.  Including all four of these 
independent variables increased the correct predictability of the model to 69.1% which 
was the highest percent for all possible combinations.  With this model, age has an 
Exp(β) = .762, p=.001.  Kidney failure calculated as Exp(β) = 3.136, p=.006, solid organ 
tumor cancer was similar with Exp (β) = 3.010, p=.006.  Multiple organ failure had 
Exp(β) = .306, p=.008.  Further exploration using a multinomial logistic regression 
produced similar results.  For the risk of CABSI the age group of 24-35, kidney failure, 
solid organ tumor cancer, and multiple organ failure were all still statistically significant 
(see Table 20).   
Table 20 Risk of CABSI Using Multinomial Logistic Regression 
 
 Exp (B) Sig. 
Age (25-34) 9.52 <.0001 
Kidney Failure .71 <.0001 
Solid Organ Tumor Cancer .71 <.003 
Multiple Organ Failure 2.80 .005 
 
It is important to note that for multiple organ failure, β= -1.129 which indicates 
that there was a decrease in odds of having CABSI with multiple organ failure. This 
model correctly predicted 69.5% of the cases which was slightly higher than the predicted 





Information discovered from this study may allow for practical measures to be 
taken to disrupt the epidemiologic triangle and prevent Candida albicans bloodstream 
infections in hospitalized patients.  Essential oils such as lemongrass, oregano, and thyme 
have shown to be statistically superior at killing Candida albicans in laboratory testing.  
This information can be used in areas of cleaning as well as patient care.  The reduction 
of the virulence factor germ tube production when exposed to LTO provides areas to 
improve patient outcomes with potential decrease in virulence of Candida albicans that 
the patient may be exposed to in the environment.  Data analysis of risk factors provide 
areas to target protocols that could reduce patient risk for acquiring Candida albicans 
bloodstream infections while in the hospital.  In Chapter 4 I presented procedures used 
for this data analyses as well as the analyses for the seven hypotheses for this study. 
Of the seven hypotheses examined, all seven null hypotheses were rejected.  A 
significant difference in kill rates existed for each essential oil, the combined essential 
oils LTO, as well as LTO plus caspofungin or fluconazole when compared to 
caspofungin or fluconazole alone.  LTO significantly reduced the germ tube production 
of the Candida albicans isolates tested when compared to reduction of germ tube 
production using caspofungin or fluconazole.  Risk factors that were statistically 
significant for Candida albicans bloodstream infections included age 25-34, kidney/renal 
failure, solid organ tumor cancer, and multiple organ failure.  While these risk factors 
cannot be controlled, knowing that a patient has one or more of these risk factors could 




hand hygiene for each person entering these patient rooms.  In Chapter 5 I will present 
details of the interpretations of the findings of this study, the associated findings, as well 
as strengths and limitations of the study.  In addition, future recommendations for 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this study was to investigate the impact of lemongrass, oregano, 
and thyme essential oils individually and combined on Candida albicans ability to 
reproduce in comparison to the antifungal medications, caspofungin and fluconazole 
individually, and with the combined essential oils.  Additional studies were performed to 
determine whether the combined essential oils, caspofungin, or fluconazole inhibited the 
virulence factor of germ tube production in Candida albicans isolates.  The patient 
demographics collected from patients with Candida albicans bloodstream infections were 
compared to a control group of patients with blood cultures collected during the same 
collection period without Candida albicans bloodstream infections to determine whether 
age, race, gender, or comorbidities contributed to risk factors for these bloodstream 
infections.   
This study was quantitative in nature with experimental data collected for the first 
six research questions and secondary data collected on patient demographics to evaluate 
the seventh research question.  Patients who acquire Candida bloodstream infections 
during hospital stays have been shown in previous research to have a 30-day mortality 
rate between 31 to 61% (Diekema, Arbefeville, Boyken, Kroeger, & Pfaller, 2012).  
Calculating 30-day mortality rates for this study was beyond the scope of this research.  
Future studies incorporating essential oils in different modalities and comparing mortality 
rates of pre and post-incorporation would provide data on whether long-term 




lemongrass, oregano, thyme, and the oils blended together had statistically significant 
higher kill rates on Candida albicans.  isolates than caspofungin and fluconazole.  In 
addition, combining the blended oils with caspofungin or fluconazole also statistically 
significantly improved the levels of kill rates compared to using caspofungin or 
fluconazole alone.  Germ tube virulence factors were also inhibited by the combined 
treatment of lemongrass, oregano, and thyme.  There was no statistically significant 
inhibition of germ tube production with either caspofungin or fluconazole.  Risk factors 
that were statistically significant in contributing to Candida albicans infections included 
the age group of 23-34 and the comorbidities of kidney failure, solid organ tumor cancer, 
and multiple organ failures.  These findings will be discussed in more detail in the 
following section. I will also discuss limitations of the study, recommendations for future 
research, and implications for social change. 
Interpretation of the Findings 
Lemongrass, thyme, and the three combined essential oils showed statistically 
significant impact on the kill rates of the Candida albicans isolates tested over time.  
Oregano did not have a statistically significant impact over time due to the high kill rates 
after 1 hour.  After allowing for a 48-hour growth period on culture plates to determine 
whether the effect on the colonies were merely inhibition and not cell death, exposure to 
lemongrass after 12 hours resulted in a mean colony growth of zero.  The colonies were 
no longer viable after being exposed to lemongrass for 12-hours.  Oregano and thyme 
both had a mean colony count of zero after only 4 hours of exposure of the isolates to the 




similar result as lemongrass alone with the zero-growth rate of colonies after 12 hours.  
The impact of lemongrass had previously been reported to have similar activity to 
nystatin orally to treat oral yeast infections by Amornvit (2014).  Although nystatin 
cannot be used for invasive infections, lemongrass appeared in this study to have a higher 
efficacy of yeast cellular death than either caspofungin or fluconazole which are used to 
treat systemic fungal and yeast infections.  Oregano and thyme in this study yielded 
similar results that have previously been reported.  Bellete et al. (2012) reported that low 
concentrations of thyme essential oil were shown to be effective at inhibiting Candida 
species.  Omran and Esmailzadeh (2009) supported the evidence drawn from this study 
that thyme has a higher level of inhibition than fluconazole; however, zones of inhibition 
were used instead of verifying whether the organism is in fact killed when exposed to 
thyme essential oil.  I found that the organisms were killed when exposed to thyme and 
not just inhibited.  Pozzatti et al. (2008) indicated that Candida albicans isolates that 
were resistant to fluconazole were highly susceptible to oregano essential oils.  I found 
that all Candida albicans isolates were highly susceptible to exposure to oregano after 
only 1 hour.  Although this study supported previous research that indicated the essential 
oils lemongrass, oregano, and thyme were effective at inhibiting Candida albicans, it also 
showed that the oils were effective at killing the isolates in less than 24-hours.  Although 
neither of the antifungals tested during this study were able to obtain a mean colony 
count of zero, caspofungin had the lowest mean colony count of 8.76 after an 8-hour 




lowest of its colony counts at the 4-hour exposure time of 53.47 but then the colony 
counts increased after further exposure.   
After the initial inoculation of the essential oils or antifungals, no additional 
treatments were added to the organisms growing in TSB.  The essential oils continued to 
kill the Candida albicans isolates, while the antifungals were able to inhibit temporarily, 
but without additional treatments the organisms were able to overcome exposure and 
continued to proliferate.  Combining the essential oils and antifungals did not prevent the 
essential oils from killing the isolates; however, the combination of LTO and fluconazole 
had a mean rate of 0 which was slightly lower after 8 hours of exposure compared to 
LTO and caspofungin, which had a mean colony count of 0.05 after 8 hours.  The 
addition of the combined essential oils did not inhibit the action of fluconazole or 
caspofungin to the Candida albicans isolates, but rather provided an additional 
mechanism to kill the organisms instead of merely inhibiting the growth of the 
organisms.  Although the use of the combined LTO did not completely kill after 1 hour of 
exposure, it did still show statistically significant inhibition of the virulence factor of 
germ tube production in laboratory testing. 
Testing for germ tube production while simultaneously incubating isolates with 
either LTO, caspofungin, or fluconazole also validated potential uses of lemongrass, 
oregano, and thyme essential oils.  The combined LTO essential oils inhibition of germ 
tube production was statistically significant at the 0.05 critical alpha level.  This 
corresponds to previous research by Gaspar De Toledo et al. (2016) who indicated that 




to inhibit virulence factors, such as proteinase, haemolysin, and biofilm production by 
Khan, Ahmad, Cameotra, and Botha, (2014).  Not only was germ tube production was 
prevented, but biofilm development was diminished when used against Candida albicans 
(Rodrigues, Rodrigues, Silva, & Henriques, 2017).  Exposure to caspofungin and 
fluconazole did not decrease germ tube production.  Two isolates with exposure to 
caspofungin and two different isolates exposed to fluconazole created germ tubes when 
exposed to the antifungals but not when these four isolates were incubated only in the 
germ tube medium.  Fluconazole was unable to disrupt virulence factors in Candida 
albicans (Khan et al., 2014).  This phenomenon for lemongrass, oregano, and thyme to 
disrupt virulence factors poses an interesting aspect for further research.  Additional 
research into potential risk factors rounded out this study of Candida albicans 
bloodstream infections. 
The potential risk factors for CABSI that were examined included, race, gender, 
age, and comorbidities.  Previous research by Yang et al. (2014) indicated that advanced 
age and neutropenia were risk factors for Candida sepsis, however, for this research 
group, the statistical significance for age as a risk factor was in a lower age group of 25-
34.  In this study, gender and race were not statistically significant as had previously been 
reported for all types of bloodstream infections by Kaye et al. (2011). A study by 
Diekema et al. (2012) examining data from 1983 through 2007 reported that the mean 
age in years ranged from 38 to 45.8 depending on the years of data collected for health 
care associated Candida infections but the research did not list the age range of the data 




unfortunately did not compare a control group to evaluate whether age was a risk factor.  
It may also be relevant to note that the closer age-range from the Diekema et al., (2012) 
study was from data collected in Iowa and the Yang et al., (2014) study was in Shanghai.  
Additional nationwide research may shed light on whether age range is statistically 
significant for risk factors of Candida albicans bloodstream infection and whether the 
age range is consistently younger than reported in other countries.  More in-depth 
analysis of other factors for the 25-34 age group may provide additional insight for 
preventative measures in the future.  The relationship between the comorbidities of renal 
failure, solid organ cancer, and multiple organ failure with CABSI were all statistically 
significant; however, patients with multiple organ failure were at a decreased risk of 
CABSI whereas renal failure and solid organ tumor cancer were positively related to 
acquiring CABSI while hospitalized.  Recognizing these potential risk factors can 
provide areas to target for interventions to reduce the risk of Candida albicans 
bloodstream infections.  Data collected by Diekema et al., (2012) for 108 cases from 
2004-2007 had surgery as the most patients with healthcare acquired Candida infections.  
Again, without a comparison group, it is unknown whether this data reported by Diekema 
et al., (2012) was statistically significant.  In the study by Yang et al. (2014), neutropenia 
was the most common comorbidity but there was no control group to compare for 
statistical significance.  While Kaye et al. (2011) indicated that obesity, surgery, and 
previous hospital exposure were risk factors, the study only evaluated patients that were 
in the age range of 69-79 and they examined all bloodstream infections, not just Candida 




infections occurred in the Japanese study were under the age of 70 with cardiovascular 
disease and surgery the more common comorbidities.  Similar to the age group risk 
factors, additional national research may indicate whether certain comorbidities are 
significant risk factors for patients in the United States or perhaps in regions of the 
United States.  
Using the theoretical framework of the epidemiological triangle for this study 
provided a foundation for potential areas of prevention and improving patient outcomes.  
Recognizing potential risk factors such as age and comorbidities provides areas of 
intervention including additional patient precautions for patients with these risk factors, 
prudent hand washing by visitors and care providers, as well as studying the effects of 
developing interventions such as diffusing the essential oils in patient rooms to 
potentially disrupt the organism’s ability to survive in the host environment or topically 
applying the essential oils to prevent colonization of Candida on skin surfaces.  Further 
studies in disrupting the epidemiological triangle would be warranted to verify these 
areas as opportunities to prevent infections. 
Limitations of the Study 
Limitations to this study include the ability to apply this research to the general 
population at large.  This study examined the patient demographics and characteristics of 
Candida albicans isolates from a large adult teaching hospital which may not apply to 
smaller community hospital patients and the isolates recovered from these smaller 
facilities.  The adult age range of 18-74 may also limit the generalizability to the general 




studied.  Other potential limitations include the lack of further investigation into why the 
age range of 25-34 was a risk factor.  In addition, the ability to gather demographics and 
isolates from other institutions was beyond the scope of this study.  The experimental 
data collected was from previously frozen isolates and this could have resulted in 
organisms that were not as robust compared to the initial isolation of these organisms.  
Controls and comparisons were built in to minimize this potential limitation.  
Furthermore, how Candida albicans would react to the eight interventions while actively 
infecting a patient was not determined.  Any discrepancy between in-vitro and in-vivo 
results due to host response to colonization versus invasive Candida albicans infections 
could not be determined in this study.  These limitations; however, also provide areas for 
continued research. 
Recommendations 
The ability to provide a large sample size to study at a large teaching hospital 
provided opportunities for future research.  Areas for recommended further study include 
whether diffusion of these essential oils in patient rooms could decrease the number of 
Candida albicans infections as well as other Candida infections.  In addition, further 
investigations as to whether other Candida species such as Candida glabrata react in 
similar manners when exposed to these essential oils compared to Candida albicans 
could also prove to be beneficial.  Candida albicans isolates had a disruption of germ 
tube production when exposed to lemongrass, oregano, and thyme.  Whether this is a 
permanent disruption or whether the organism, if still viable, would be able to make germ 




there has been research involving the effect of lemongrass, oregano and thyme on 
Candida isolates (Amornvit et al., 2014; Bellete et al., 2012; Boukhatem, Ferhat, Kameli, 
Saidi, & Kebir, 2014; Nasir, Tafess, & Abate, 2015; Omran & Esmailzadeh, 2009; 
Pozatti et al., 2008), the possibility of studying not only the effects of the oils on Candida 
species, but also on how the patient responds to the oils being diffused or applied 
topically remains to be determined again with future research.  This study provided 
additional information using a larger sample size as well as investigation into possible 
combination therapy treatments. I will discuss further implications in the following 
section. 
Implications 
Based on this research, further implications for positive social change include the 
ability to improve the public’s health by limiting potential transmission of multi-drug 
resistant yeast to others in the general population.  This would be due to fewer Candida 
isolates surviving long-term treatment with antifungal medications and therefore reducing 
the likelihood of developing resistance to these drugs.  With less multi-drug resistant 
isolates developing, fewer of these isolates would be in circulation (CDC, 2011).  
Information collected from this study could improve outcomes by targeting risk factors 
for prevention and utilizing the essential oils from this research to disrupt the 
epidemiological triangle and prevent infections from occurring while higher risk patients 
are hospitalized.  Reducing hospital acquired infections caused by Candida and other 
organisms reduces the cost for the hospital and the patient (CDC, 2013).  Decreasing 




Improved patient outcomes in clinics and hospital not only impacts the financial cost but 
also the associated emotional and physical costs related to long-term illnesses on both the 
family and patient,   
The information collected from this study could provide a foundation for future 
research involving other microbes and the effects of the interactions with essential oils to 
reduce infection rates.  Reduction of hospital acquired Candida infections could decrease 
mortality rates and improve patient outcomes both while hospitalized and after discharge 
by decreasing the likelihood of colonization and thus decreasing the potential risk of 
infections of these patients.  Reduction of these hospital acquired infections could also 
decrease lengths of stay, decrease hospital charges to the patient, and decrease overall 
hospital expenses. 
Providing opportunities to change the environment of the patient’s room while 
hospitalized would enable a reduction in the risk of infections while also giving patients 
and their care givers the possibility to continue this mode of disruption for Candida 
survival outside the hospital setting thus enabling self-care once the patient was 
discharged.  Additional research into potential modalities of treatment with essential oils 
(aromatic, topical, or internal) in conjunction with standard medical treatment could open 
additional areas for improving patient outcomes.  Introduction of aromatic methods into a 
hospital setting could be beneficial to the hospital as well as the patient.  Targeting at-risk 
patients to receive additional essential oil treatments whether it is simply diffusing 
antifungal essential oils in the room during their stay or providing essential oils as 




monitored and the aromatic treatment modality could be validated as a new standard of 
care.  This in turn could lead to expansion into the additional treatment modalities in a 
controlled research setting to monitor for improvement of patient outcomes.  Improving 
patient outcomes has a positive effect on the people, their families, and the communities 
they live in.  This can be achieved by decreasing patient length of stays in hospitals, 
which in turn enables them to return to their communities, families, and way of life 
sooner.  This can also create ways to enable preventative care methods that prevent 
additional hospitalizations, which then reduces financial burdens for the hospital, the 
patient and those caring for them. 
 Conclusion 
This study was used to examine a multitude of data that was created and collected 
in the laboratory setting as well as investigating risk factors for CABSI at a large teaching 
hospital with various patient demographics and comorbidities.  Lemongrass, oregano, 
thyme, and the three essential oils combined all showed statistically significant 
improvement over caspofungin and fluconazole to not only inhibit Candida albicans 
from growing but to also kill it within a brief time period.  The ability for these oils to 
rapidly kill Candida albicans not only decreases the likelihood of the development of 
drug resistance but also minimizes the chance that the organism would contaminate the 
environment and be spread to other areas and patients.  Prevention of the germ tube 
production virulence factor provides an exciting area for additional research on 
preventing not only severe Candida albicans infections but less serious but troublesome 




providers to concentrate on other aspects of admission without introducing an additional 
life-threatening infection that needs to be aggressively and rapidly treated (CDC, 2011).  
Further studies are needed to better understand the interactions of host cells, invading 
organisms, and how essential oils interact in-vivo.  While synthetic antimicrobial options 
are very limited, and organisms have often developed resistance prior to the treatment 
being approved for use on the public (CDC, 2011), essential oils provide a means to 
potentially prevent infections and reduce resistance. 
Anyone that has had a yeast infection regardless of the severity could potentially 
benefit from this research for viable alternative treatment options.  Hospitals and clinics 
could benefit from this information by being able to reduce costs and improve patient 
outcomes (Bliss et al., 2012).  The ability to provide new ways for patients to engage in 
treatment regimens helps to empower patients and their families by providing 
opportunities to actively participate in the treatment plan which in turn can improve 
outcomes and patient satisfaction.  Research and inception of new treatment modalities 
are rapidly needed in the United States to reduce mortality rates due to preventable 
infections (CDC, 2011).  The addition of essential oils into standard of care warrants 
serious consideration and research such as this study continue to provide proof of validity 
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